Idiopathic gout

GOUT_IDIO

gout: A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M10.0 Cause of death: ICD-10 — M10.0 2 out of 7 registries used, show all original rules.	3338
4. Check minimum number of events None	3338
5. Include endpoints None	3338
6. Filter based on genotype QC (FinnGen only)	3338

Control definitions (FinnGen only)

Control exclude: GOUT

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M10
Name in latin: Arthritis urica idiopathica

NAME	GOUT_IDIO
CONTROL_EXCLUDE	GOUT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M100
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M100
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Idiopathic gout based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	24455	6615	17693
Only index persons	21996	5824	16172
Unadjusted period prevalence (%)
Whole population	0.41	0.19	0.49
Only index persons	0.51	0.21	0.62
Median age at first event (years)
Whole population	70.11	77.39	67.37
Only index persons	69.50	76.90	66.83

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3338	724	2614
Unadjusted period prevalence (%)	0.96	0.25	1.15
Median age at first event (years)	68.54	71.30	67.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2936: Matched controls
29362

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

212

Kela drug reimbursment

Gout

+∞

323.0

518

M10.0

ICD-10 Finland

Idiopathic gout

12059.7

323.0

2901

228

M10.9

ICD-10 Finland

Gout, unspecified

59.9

323.0

1524

520

M04AA01

ATC

allopurinol; systemic

59.7

323.0

2452

2295

M10

ICD-10 Finland

Gout

16.5

323.0

754

602

H02AB06

ATC

prednisolone; systemic

5.3

323.0

2123

9654

A46

ICD-10 Finland

Erysipelas

5.2

272.8

1022

2715

C03CA01

ATC

furosemide; systemic

4.0

263.4

1643

7109

M13.9

ICD-10 Finland

Arthritis, unspecified

8.4

252.0

604

876

T92

ICPC

Gout

16.2

194.8

326

225

M01AB01

ATC

indometacin; systemic, rectal

5.3

189.1

657

1520

I10

ICD-10 Finland

Essential (primary) hypertension

3.3

175.7

2300

15239

I50.9

ICD-10 Finland

Heart failure, unspecified

3.7

168.9

897

3087

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.7

167.9

533

1096

205

Kela drug reimbursment

Chronic hypertension

3.0

167.9

1445

7111

288

Kela drug reimbursment

Febuxostat

165.7

150.0

157

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.9

137.8

1160

5420

J01DB01

ATC

cefalexin; oral

3.4

136.2

2538

19174

M04AA03

ATC

febuxostat; oral

163.2

133.6

140

349

Kela drug reimbursment

Febuxostat

179.5

131.6

137

C07AB07

ATC

bisoprolol; oral

2.6

131.0

1882

11915

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.7

121.3

1197

6037

M01AH05

ATC

etoricoxib; oral

2.5

119.0

1785

11282

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

113.0

1674

10386

B01AA03

ATC

warfarin; systemic

2.6

110.6

1061

5193

C08CA01

ATC

amlodipine; oral

2.4

109.1

1468

8607

A10BA02

ATC

metformin; oral

2.5

104.5

1217

6576

L17

ICPC

Foot/toe symptom/complaint

2.7

104.4

933

4352

I50.0

ICD-10 Finland

Congestive heart failure

3.8

101.6

486

1460

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

5.6

100.2

315

620

C03DA01

ATC

spironolactone; oral

3.3

99.1

578

2028

103

Kela drug reimbursment

Diabetes, insulin-treated

2.4

99.1

1169

6306

N02BE01

ATC

paracetamol; systemic, rectal

3.1

98.9

2602

21083

M79.6

ICD-10 Finland

Pain in limb

2.4

97.9

1161

6272

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.5

97.2

1042

5336

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.4

96.1

382

966

T90

ICPC

Diabetes non-insulin dependent

2.5

95.8

1019

5186

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.8

93.9

342

791

J01FF01

ATC

clindamycin; systemic

2.5

93.3

997

5069

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.2

91.2

1481

9213

N02AX02

ATC

tramadol; systemic, rectal

2.2

90.6

1501

9413

A02BC02

ATC

pantoprazole; systemic

2.3

90.3

2046

14792

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

8.3

88.1

204

262

M25.5

ICD-10 Finland

Pain in joint

2.5

87.4

857

4135

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

87.3

575

2180

N18.8

ICD-10 Finland

Other chronic renal failure

6.5

87.0

239

395

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.0

79.3

518

1941

E66.00

ICD-10 Finland

Metabolic syndrome

4.7

79.2

292

680

M10.3

ICD-10 Finland

Gout due to impairment of renal function

109.4

78.3

A11CC03

ATC

alfacalcidol; systemic

7.9

78.2

186

249

R60.0

ICD-10 Finland

Localized oedema

3.0

77.7

507

1894

N19

ICD-10 Finland

Unspecified kidney failure

5.1

77.2

259

545

R06.0

ICD-10 Finland

Dyspnoea

2.3

74.5

915

4872

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

70.6

805

4115

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.3

70.5

176

253

C09AA02

ATC

enalapril; systemic

2.2

69.2

862

4590

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

66.4

984

5638

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.3

64.9

257

639

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

64.9

747

3811

207

Kela drug reimbursment

Chronic arrhythmias

2.3

64.8

702

3477

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

64.3

1135

6967

E66.01

ICD-10 Finland

Obesity due to excess calories

4.2

63.9

261

668

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.3

63.6

695

3453

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

61.0

691

3482

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

60.5

597

2807

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

60.0

684

3455

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.7

59.5

450

1825

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

58.4

856

4824

S97

ICPC

Chronic ulcer skin

3.5

58.2

297

918

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.4

57.6

310

998

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

56.5

508

2266

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

55.6

936

5558

H02AB07

ATC

prednisone; oral

2.5

55.6

520

2366

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

55.5

1009

6176

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.3

55.3

220

548

C02AC05

ATC

moxonidine; oral

3.7

53.6

254

738

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.2

53.3

214

537

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.6

53.1

259

771

I43.8*M10.0

ICD-10 Finland

Gout in the heart

+∞

52.2

C08CA13

ATC

lercanidipine; oral

2.4

52.2

530

2509

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.2

52.0

624

3201

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

51.6

962

5905

R4110

NOMESCO Finland

Physiotherapy

2.0

51.1

866

5124

C01AA05

ATC

digoxin; systemic

2.6

50.6

412

1731

L28

ICPC

Limited function/disability (L)

2.2

50.3

597

3039

J01MA12

ATC

levofloxacin; systemic

2.1

50.2

702

3839

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

50.0

586

2964

A10BH05

ATC

linagliptin; oral

3.4

49.8

264

838

C09CA01

ATC

losartan; oral

2.0

48.8

850

5067

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

48.4

463

2119

B01AB05

ATC

enoxaparin; parenteral

1.9

48.2

987

6231

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

8.9

48.1

105

122

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

47.7

458

2098

J01DA01

ATC

[U] cefalexin; systemic

1.8

47.3

1778

13643

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

47.3

646

3487

G47.3

ICD-10 Finland

Sleep apnoea

2.0

47.1

746

4274

A12AA04

ATC

calcium carbonate; oral

7.3

46.7

115

162

C10AA05

ATC

atorvastatin; oral

1.8

46.5

1362

9647

C01DA14

ATC

isosorbide mononitrate; oral

2.0

46.5

712

4024

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

46.0

296

1073

TK800

NOMESCO Finland

Hemodialysis

5.5

45.7

140

264

B01AF02

ATC

apixaban; oral

2.4

44.4

433

1994

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

44.1

582

3085

I50.1

ICD-10 Finland

Left ventricular failure

3.1

43.9

262

904

M10.1

ICD-10 Finland

Lead-induced gout

+∞

43.8

C03AA03

ATC

hydrochlorothiazide; oral

2.5

43.8

391

1719

M13.0

ICD-10 Finland

Polyarthritis, unspecified

8.9

43.2

109

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

43.2

480

2354

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.3

43.1

235

760

K78

ICPC

Atrial fibrillation/flutter

2.5

42.8

380

1666

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

42.8

914

5797

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

42.6

541

2816

A10BH01

ATC

sitagliptin; oral

2.4

42.3

405

1844

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

6.1

42.0

118

200

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

41.6

485

2427

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

41.5

369

1617

N03AX16

ATC

pregabalin; oral

1.9

41.3

712

4180

C10AA01

ATC

simvastatin; oral

1.7

41.3

1577

11929

S18

ICPC

Laceration/cut

1.7

41.1

1309

9385

R03AC02

ATC

salbutamol; inhalant

1.7

41.1

1350

9767

M70.2

ICD-10 Finland

Olecranon bursitis

3.7

41.0

190

541

L15

ICPC

Knee symptom/complaint

2.0

40.5

593

3263

L16

ICPC

Ankle symptom/complaint

2.6

40.5

311

1257

C09AA05

ATC

ramipril; oral

1.8

40.4

944

6146

R50.9

ICD-10 Finland

Fever, unspecified

2.2

40.4

481

2430

E66.8

ICD-10 Finland

Other obesity

4.1

40.2

166

427

M10.2

ICD-10 Finland

Drug-induced gout

66.6

40.1

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

40.0

310

1257

I50

ICD-10 Finland

Heart failure

3.7

39.7

180

503

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

39.6

536

2855

N18.0

ICD-10 Finland

End-stage renal disease

7.5

39.4

130

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

39.1

472

2396

C09CA06

ATC

candesartan; oral

1.9

39.1

648

3736

AN1

Coronary angiography

2.1

39.0

531

2835

M01AE02

ATC

naproxen; oral, rectal

1.7

38.9

1449

10804

C07AB02

ATC

metoprolol; systemic

1.8

38.7

770

4739

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

38.7

263

985

I42.0

ICD-10 Finland

Dilated cardiomyopathy

4.0

38.2

162

427

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

37.5

927

6110

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

37.1

472

2445

J01CE02

ATC

phenoxymethylpenicillin; oral

1.7

37.0

1788

14237

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.5

37.0

308

1301

A28

ICPC

Limited function/disability NOS

2.0

36.9

566

3163

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

36.7

726

4446

C08CA02

ATC

felodipine; oral

2.2

36.5

407

1987

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

36.4

377

1779

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

36.3

900

5926

ZXA05

NOMESCO Finland

Left side

1.8

36.3

828

5312

L04AA06

ATC

mycophenolic acid; systemic

6.2

36.2

100

166

NHQ40

NOMESCO Finland

Amputation of toe

5.1

35.8

116

234

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.6

35.5

274

1107

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

35.4

1065

7412

A10AE04

ATC

insulin glargine; parenteral

2.3

35.3

370

1754

AA1AD

NOMESCO Finland

CT of head and brain

1.8

35.3

817

5256

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

35.2

357

1665

H02AB04

ATC

methylprednisolone; systemic

2.1

35.2

441

2266

M13.8

ICD-10 Finland

Other specified arthritis

12.3

35.2

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

35.0

503

2733

E66.9

ICD-10 Finland

Obesity, unspecified

4.8

34.6

120

260

SPAT1262

SPAT

Handing over of treatment supplies

1.9

34.6

654

3931

127

Kela drug reimbursment

Transplant complication

6.6

34.5

142

R04.0

ICD-10 Finland

Epistaxis

2.4

34.2

305

1334

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.9

33.9

224

824

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.8

33.7

236

900

TFP20

NOMESCO Finland

Cardiodefibrillation

2.3

33.7

342

1595

E87.5

ICD-10 Finland

Hyperkalaemia

5.1

33.6

109

220

ZXA00

NOMESCO Finland

Right side

1.7

33.6

847

5575

Z94.0

ICD-10 Finland

Kidney transplant status

8.0

33.6

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

9.9

33.5

R02

ICPC

Shortness of breath/dyspnoea

2.2

33.4

392

1954

S76

ICPC

Skin infection other

3.0

33.3

203

708

C02EA02

ATC

2.8

33.2

225

841

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.2

32.9

115

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

32.8

397

2006

M10.4

ICD-10 Finland

Other secondary gout

91.1

32.8

A12BA01

ATC

potassium chloride; oral

2.9

32.7

208

745

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

32.7

945

6464

C09BA02

ATC

enalapril and diuretics; systemic

2.2

32.6

356

1716

J01MA02

ATC

ciprofloxacin; systemic

1.6

32.4

1228

9032

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.4

32.3

289

1264

C09CA03

ATC

valsartan; oral

2.2

31.9

346

1661

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.0

31.8

189

648

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.0

31.0

148

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.1

30.9

181

612

B03XA02

ATC

darbepoetin alfa; parenteral

5.0

30.5

101

209

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.0

30.5

434

2340

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.5

30.2

111

256

SPAT1255

SPAT

Intravenous administration of medicine

2.5

30.0

255

1084

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.8

29.8

130

352

WX892

NOMESCO Finland

Monitored bed care

2.3

29.8

299

1384

SPAT1263

SPAT

Sampling

1.6

29.7

1166

8599

Z71.8

ICD-10 Finland

Other specified counselling

1.8

29.6

590

3586

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

29.5

892

6141

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

29.4

543

3218

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.0

29.3

106

B01AC04

ATC

clopidogrel; oral

1.8

29.2

627

3899

A10BB12

ATC

glimepiride; oral

2.2

29.1

326

1587

WX002

NOMESCO Finland

Sedation and analgesia

1.8

29.1

600

3681

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

4.0

28.9

119

306

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

9.1

28.9

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.6

28.9

231

951

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

28.9

281

1281

A08

ICPC

Swelling

3.1

28.8

165

552

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

28.7

355

1803

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

28.7

828

5618

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

28.4

249

1076

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

28.4

239

1009

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

8.0

28.4

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.5

28.3

230

953

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

6.8

28.2

108

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

27.7

876

6080

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

27.5

766

5132

N02AA05

ATC

oxycodone; systemic

1.8

27.5

514

3050

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.1

27.3

332

1671

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

27.1

787

5330

2740A

ICD-9 Finland

Gouty arthropathy

+∞

27.1

J01FA06

ATC

roxithromycin; oral

1.6

27.1

1042

7591

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.6

26.8

125

358

N03AX12

ATC

gabapentin; oral

1.9

26.8

438

2477

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

26.8

311

1535

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

26.7

428

2402

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.2

26.7

165

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.9

26.6

166

588

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.9

26.4

167

597

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

26.3

630

4033

C07AG02

ATC

carvedilol; oral

2.3

26.3

253

1144

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

4.6

26.1

204

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

26.0

267

1246

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.3

26.0

249

1125

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

25.9

555

3433

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.2

25.7

276

1314

137

Kela drug reimbursment

Uraemia requiring dialysis

8.1

25.6

M54.5

ICD-10 Finland

Low back pain

1.6

25.5

800

5518

SPAT1254

SPAT

Administration of medicine

1.8

25.3

464

2725

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.1

25.3

102

258

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

25.1

759

5178

J01CA04

ATC

amoxicillin; systemic

1.5

25.1

2046

17580

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.3

25.1

253

1170

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

24.9

254

1180

J01CF05

ATC

flucloxacillin; systemic

3.0

24.8

145

492

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

24.4

301

1522

V03AE02

ATC

sevelamer; oral

12.8

24.3

K07

ICPC

Swollen ankles/oedema

2.8

24.3

167

627

WX110

NOMESCO Finland

Local anesthesy

1.5

24.3

1718

14243

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

24.0

690

4635

K77

ICPC

Heart failure

3.9

24.0

100

261

ZX120

NOMESCO Finland

Intravenous

2.0

24.0

312

1612

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

23.7

378

2114

UJF32

NOMESCO Finland

Coloscopy

1.6

23.6

769

5338

C09DA06

ATC

candesartan and diuretics; oral

2.2

23.5

245

1150

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.2

23.5

125

397

E0000UV

ATC

1.5

23.2

961

7058

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

3.3

23.1

118

364

M48.0

ICD-10 Finland

Spinal stenosis

1.8

23.1

415

2420

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

9.9

23.0

J01AA02

ATC

doxycycline; systemic

1.5

23.0

2093

18207

V03AE01

ATC

polystyrene sulfonate; oral

4.9

22.8

155

D07AC01

ATC

betamethasone; topical

1.5

22.7

921

6722

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.3

22.5

118

372

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

22.4

704

4829

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.3

22.4

116

362

N05CF01

ATC

zopiclone; oral

1.5

22.3

904

6593

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.4

22.2

111

337

R03BB04

ATC

tiotropium bromide; inhalant

1.9

21.9

370

2109

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.1

21.8

256

1265

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

21.8

434

2611

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

9.3

21.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

21.7

1054

7995

N18

ICD-10 Finland

Chronic kidney disease

5.9

21.6

106

R53

ICD-10 Finland

Malaise and fatigue

1.7

21.5

560

3648

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

21.5

495

3111

SPAT1229

SPAT

Assessment of need for aid

2.0

21.4

283

1471

C08DB01

ATC

diltiazem; oral

2.2

21.4

221

1033

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

21.3

194

853

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

21.3

336

1868

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

21.2

826

5955

Z49.2

ICD-10 Finland

Other dialysis

8.0

21.2

J01CE08

ATC

benzathine benzylpenicillin; parenteral

5.8

21.1

105

I48.2

ICD-10 Finland

Chronic atrial fibrillation

3.1

21.1

120

399

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

21.1

136

492

S29

ICPC

Skin symptom/complaint other

1.7

21.0

471

2939

WX722

NOMESCO Finland

PEEP

2.4

20.9

186

806

3AC01

NOMESCO Finland

6.4

20.9

M77.4

ICD-10 Finland

Metatarsalgia

2.9

20.8

134

484

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.2

20.7

226

1084

R55

ICD-10 Finland

Syncope and collapse

1.8

20.7

367

2123

U14

ICPC

Kidney symptom/complaint

4.6

20.7

159

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.6

20.6

271

WX320

NOMESCO Finland

Spinalanesthesy

1.6

20.6

647

4421

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

20.6

524

3385

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

6.8

20.6

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

5.0

20.5

134

M01AB05

ATC

diclofenac; systemic, rectal

1.4

20.4

1705

14367

L04AD01

ATC

ciclosporin; systemic

4.3

20.3

180

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.8

20.3

348

1993

A01

ICPC

Pain general/multiple sites

2.2

20.3

218

1039

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.2

20.2

213

1007

A04

ICPC

Weakness/tiredness general

1.8

20.1

352

2028

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

20.1

160

655

L12

ICPC

Hand/finger symptom/complaint

1.8

20.0

354

2045

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

20.0

201

927

I25.2

ICD-10 Finland

Old myocardial infarction

1.9

19.9

302

1654

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

9.2

19.8

A10AE05

ATC

insulin detemir; parenteral

2.3

19.8

189

850

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

19.7

642

4423

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

19.6

148

591

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.8

19.5

131

487

C07AB03

ATC

atenolol; systemic

2.1

19.4

219

1065

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

19.4

993

7568

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

19.3

306

1702

M04AB01

ATC

probenecid; oral

26.2

19.1

XF404

NOMESCO Finland

Ambulatory ECG

1.9

19.1

307

1715

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.9

19.1

121

435

N17.8

ICD-10 Finland

Other acute renal failure

4.9

18.9

129

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.4

18.9

286

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

4.3

18.8

170

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.5

18.8

255

N02BA11

ATC

diflunisal; oral

6.9

18.5

K92.1

ICD-10 Finland

Melaena

2.2

18.5

198

941

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

18.4

191

896

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

7.0

18.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

18.3

484

3152

WX872

NOMESCO Finland

Intensive care

2.2

18.3

198

946

C01BD01

ATC

amiodarone; systemic

2.7

18.3

130

501

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.0

18.2

244

1272

E79.0

ICD-10 Finland

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

21.8

18.2

160

Kela drug reimbursment

exenatide

3.5

18.1

247

A06AD11

ATC

lactulose; oral

1.6

18.1

467

3022

SPAT1301

SPAT

No procedures

1.5

18.1

882

6632

J01MA14

ATC

moxifloxacin; systemic

1.9

18.0

278

1528

M02AA07

ATC

piroxicam; topical

1.5

18.0

957

7319

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

17.9

165

732

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.6

17.9

135

539

ZZA00

NOMESCO Finland

Split skin graft

2.7

17.9

122

458

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

9.6

17.9

E000001

ATC

1.6

17.7

497

3287

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

17.6

375

2293

L40.5

ICD-10 Finland

Arthropathic psoriasis

4.1

17.6

167

A10BH02

ATC

vildagliptin; oral

3.1

17.6

313

P01BA02

ATC

hydroxychloroquine; oral

2.2

17.5

194

935

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.4

17.5

154

668

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.5

17.3

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

3.8

17.3

194

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

17.3

190

911

ZXA10

NOMESCO Finland

Bilateral

1.6

17.3

513

3437

B01AB10

ATC

tinzaparin; parenteral

2.1

17.2

209

1048

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

10.4

17.1

196

Kela drug reimbursment

Paricalcitol and cinacalcet

9.8

17.1

XG466

NOMESCO Finland

Sleep oxymetry

2.6

17.1

125

490

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.7

17.1

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.7

17.0

118

450

R03DC03

ATC

montelukast; oral

1.8

17.0

326

1931

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.3

16.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

16.9

462

3032

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

16.9

240

1280

A02BC03

ATC

lansoprazole; oral

1.5

16.9

789

5866

I20.09

ICD-10 Finland

Unstable angina

2.0

16.8

226

1181

A02BC01

ATC

omeprazole; systemic

1.5

16.8

758

5591

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

16.8

196

969

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

7.2

16.8

WX882

NOMESCO Finland

High dependency care

3.0

16.7

101

350

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

16.7

998

7781

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

16.7

120

466

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.4

16.7

150

655

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

16.7

427

2755

R4120

NOMESCO Finland

Occupational therapy

2.2

16.6

178

845

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.2

16.6

181

869

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

16.5

163

747

SPAT1252

SPAT

Overall medication plan or its review

1.9

16.5

243

1317

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.1

16.4

186

908

C09DA03

ATC

valsartan and diuretics; oral

2.2

16.3

166

769

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

7.8

16.3

L11

ICPC

Wrist symptom/complaint

2.2

16.3

167

780

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.1

16.3

196

978

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.2

16.2

164

761

A02BC05

ATC

esomeprazole; systemic

1.4

16.2

996

7799

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.9

16.2

341

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

16.1

240

1303

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.0

16.1

327

C09CA07

ATC

telmisartan; oral

2.0

16.1

226

1199

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.1

16.1

288

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

3.7

16.1

192

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.0

15.9

223

1185

B05DA

ATC

Isotonic solutions

6.9

15.9

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

15.9

198

1006

L14

ICPC

Leg/thigh symptom/complaint

2.0

15.9

206

1062

L04AA01

ATC

[U] ciclosporin; systemic

4.2

15.8

146

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

15.8

295

1731

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

15.7

176

852

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

15.7

548

3815

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

9.2

15.6

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

15.6

756

5646

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.4

15.6

132

561

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

3.0

15.5

307

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

15.4

364

2289

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

15.4

129

546

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

15.4

1179

9572

A10BJ06

ATC

semaglutide; parenteral

2.8

15.4

101

373

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.9

15.3

165

K99

ICPC

Cardiovascular disease other

2.6

15.3

114

452

W19

ICD-10 Finland

Unspecified fall

1.8

15.2

259

1475

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

15.2

309

1862

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

15.2

946

7403

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

15.1

258

1471

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

15.1

445

2971

H05BX01

ATC

cinacalcet; oral

8.1

15.0

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.5

15.0

204

M01AH02

ATC

rofecoxib; oral

1.7

15.0

358

2262

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

15.0

152

706

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

5.1

14.8

E66

ICD-10 Finland

Obesity

2.8

14.8

345

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

11.3

14.7

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

14.7

445

2990

A10BJ02

ATC

liraglutide; parenteral

3.1

14.7

273

N06AX11

ATC

mirtazapine; oral

1.4

14.6

736

5523

K28

ICPC

Limited function/disability (K)

2.9

14.6

311

C08CA05

ATC

nifedipine; systemic

1.9

14.6

222

1213

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.7

14.6

291

1741

TK810

NOMESCO Finland

Hemofiltration

6.1

14.5

E66.0

ICD-10 Finland

Obesity due to excess calories

4.9

14.5

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

10.9

14.5

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.0

14.3

283

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.7

14.2

374

P01AB01

ATC

metronidazole; oral, rectal

1.4

14.2

842

6517

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.1

14.2

161

787

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.0

14.2

142

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.6

14.1

178

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

14.0

223

1239

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

14.0

143

666

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

14.0

198

1056

A10BK01

ATC

dapagliflozin; oral

2.3

14.0

135

612

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.3

14.0

120

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.8

13.9

318

D07AB08

ATC

desonide; topical

1.8

13.9

267

1579

E86

ICD-10 Finland

Volume depletion

2.7

13.9

375

NH1AD

NOMESCO Finland

Ankle and foot CT

3.4

13.9

201

S21

ICPC

Skin texture symptom/complaint

1.7

13.9

333

2103

C02CA01

ATC

prazosin; oral

3.0

13.9

272

I44.1

ICD-10 Finland

Atrioventricular block, second degree

2.8

13.8

337

B01AF01

ATC

rivaroxaban; oral

1.6

13.8

371

2412

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

13.8

186

974

L03

ICPC

Low back symptom/complaint

1.5

13.8

525

3716

A08AB01

ATC

orlistat; oral

7.3

13.7

C03BA11

ATC

indapamide; oral

2.6

13.7

102

407

WW200

NOMESCO Finland

Immunization

2.8

13.7

327

C10AB02

ATC

bezafibrate; oral

3.3

13.7

209

Angiography of the heart and coronary arteries

1.8

13.6

257

1510

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.1

13.6

128

321

Kela drug reimbursment

Paricalcitol and cinacalcet

7.6

13.6

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.0

13.6

264

R31

ICD-10 Finland

Unspecified haematuria

1.6

13.5

371

2427

SPAT1216

SPAT

Assessment of functional ability

1.5

13.4

458

3159

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.9

13.4

279

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

13.4

736

5602

R03BA05

ATC

fluticasone; inhalant

1.6

13.4

406

2727

M01AX17

ATC

nimesulide; oral

1.4

13.3

632

4677

WW500

NOMESCO Finland

Blood transfusion

2.3

13.3

128

580

SPAT1336

SPAT

Request for examination

2.4

13.3

115

497

N25.0

ICD-10 Finland

Renal osteodystrophy

11.5

13.3

L29

ICPC

Musculoskeletal sympt/complt other

1.9

13.3

188

1004

R04.2

ICD-10 Finland

Haemoptysis

2.2

13.2

128

583

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

4.6

13.2

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

13.2

240

1396

WX402

NOMESCO Finland

General anaesthesia

1.6

13.2

390

2600

R06AE07

ATC

cetirizine; oral

1.4

13.2

880

6933

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.7

13.2

291

1794

M25.9

ICD-10 Finland

Joint disorder, unspecified

5.5

13.1

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.2

13.1

134

624

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

13.1

242

1413

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

13.1

168

863

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.9

13.0

273

S80.0

ICD-10 Finland

Contusion of knee

2.2

13.0

136

640

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

12.9

145

707

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.7

12.9

155

T82

ICPC

Obesity

3.0

12.9

258

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.3

12.8

192

A98

ICPC

Health maint/preventive medicine

1.5

12.8

2549

23920

TNG10

NOMESCO Finland

Puncture of knee

4.8

12.8

D01AC02

ATC

miconazole; topical

1.8

12.8

246

1455

C10AX09

ATC

ezetimibe; oral

1.6

12.8

342

2223

D07XC01

ATC

betamethasone, combinations; topical

1.6

12.8

333

2152

R80

ICD-10 Finland

Isolated proteinuria

5.0

12.7

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

12.7

254

M25.4

ICD-10 Finland

Effusion of joint

4.3

12.7

108

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

12.7

247

1466

J04AB02

ATC

rifampicin; systemic

3.8

12.7

142

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

12.7

321

2055

S01.0

ICD-10 Finland

Open wound of scalp

1.8

12.6

231

1347

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

12.6

241

1422

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.9

12.6

181

972

X58

ICD-10 Finland

Exposure to other specified factors

1.6

12.6

328

2117

A10BK03

ATC

empagliflozin; oral

1.8

12.6

209

1180

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.1

12.6

149

742

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.3

12.5

196

P15

ICPC

Chronic alcohol abuse

2.7

12.5

327

RD210

NOMESCO Finland

3.7

12.5

149

3025

Kela drug reimbursment

Calcium carbonate

9.3

12.5

L20

ICPC

Joint symptom/complaint NOS

2.6

12.4

346

J45.8

ICD-10 Finland

Mixed asthma

2.6

12.4

336

A29

ICPC

General symptom/complaint other

1.6

12.4

303

1924

R03BA01

ATC

beclometasone; inhalant

1.6

12.4

330

2141

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

6.5

12.3

I20.00

ICD-10 Finland

Unstable angina

2.1

12.3

131

624

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.1

12.3

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

12.3

221

1283

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

4.2

12.2

108

S19

ICPC

Skin injury other

2.2

12.2

120

551

M70.4

ICD-10 Finland

Prepatellar bursitis

2.9

12.2

257

R4180

NOMESCO Finland

Podiatric therapy

4.6

12.2

C07BB07

ATC

bisoprolol and thiazides; systemic

2.2

12.2

123

573

M01AX05

ATC

glucosamine; oral

1.5

12.1

534

3883

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.0

12.1

239

D05AX52

ATC

calcipotriol, combinations; topical

2.0

12.1

154

788

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

12.1

357

2377

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

12.1

219

1272

C09DX04

ATC

valsartan and sacubitril; oral

4.3

12.0

100

R96

ICPC

Asthma

1.8

12.0

199

1122

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

12.0

201

1138

K02.1

ICD-10 Finland

Caries of dentine

1.3

12.0

1226

10289

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

12.0

234

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.2

12.0

119

548

M07.3

ICD-10 Finland

Other psoriatic arthropathies

4.4

12.0

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

4.6

12.0

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

12.0

138

680

WX290

NOMESCO Finland

Other blockade of nerve

1.4

11.9

855

6793

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.7

11.9

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

11.9

318

2066

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

11.8

116

533

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

11.8

118

546

J46

ICD-10 Finland

Status asthmaticus

2.9

11.8

260

C02LM02

ATC

3.3

11.8

178

ND1AD

NOMESCO Finland

Wrist CT examination

5.6

11.8

WX213

NOMESCO Finland

Lower leg blockade

4.8

11.7

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.4

11.7

163

R05

ICD-10 Finland

Cough

1.5

11.7

454

3218

SPAT1310

SPAT

Counselling related to known health issue

1.4

11.7

791

6223

A10BX04

ATC

[U] exenatide; parenteral

4.1

11.7

108

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

11.7

528

3859

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

11.6

241

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

11.6

236

1421

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

11.6

163

869

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.3

11.6

101

439

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.2

11.6

186

L04AX01

ATC

azathioprine; systemic

2.3

11.6

108

483

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.1

11.5

126

609

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.5

11.5

377

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

11.5

295

1898

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

11.4

134

666

R05

ICPC

Cough

1.5

11.4

481

3465

B05DB

ATC

Hypertonic solutions

6.4

11.4

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.7

11.4

279

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.2

11.3

115

537

TK820

NOMESCO Finland

Peritoneal dialysis

7.9

11.3

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.8

11.3

126

J45

ICD-10 Finland

Asthma

1.8

11.3

198

1137

SPAT1204

SPAT

Arthrocentesis

4.5

11.3

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

11.3

592

4448

D07AC13

ATC

mometasone; topical

1.4

11.3

686

5294

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

11.2

190

1078

NG1DA

NOMESCO Finland

X-ray of knees

3.3

11.2

174

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

11.2

160

858

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.8

11.2

188

1067

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

11.2

225

1353

A91

ICPC

Abnormal result investigation NOS

2.2

11.1

113

528

SPAT1260

SPAT

Consultation of another employee

1.5

11.1

449

3207

S06

ICPC

Rash localized

2.0

11.1

138

703

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.0

11.1

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.0

11.0

148

775

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.7

11.0

280

J01DC02

ATC

cefuroxime; systemic

2.1

11.0

129

642

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

11.0

386

2674

R03AC03

ATC

terbutaline; inhalant

1.6

11.0

293

1903

R4190

NOMESCO Finland

Nutritional therapy

2.5

11.0

360

C07AA07

ATC

sotalol; systemic

2.0

10.9

135

686

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

10.9

180

1013

B80

ICPC

Iron deficiency anaemia

3.1

10.9

189

C10AA04

ATC

fluvastatin; oral

1.6

10.9

286

1847

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.6

10.9

318

C09AA03

ATC

lisinopril; oral

1.9

10.9

155

831

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

10.9

338

2280

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.2

10.8

107

495

C10AA07

ATC

rosuvastatin; oral

1.4

10.8

669

5171

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

10.8

401

2809

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.7

10.8

241

1490

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.7

10.8

208

1234

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

10.8

321

2139

R11

ICD-10 Finland

Nausea and vomiting

1.8

10.8

179

1010

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.0

10.8

144

752

RS221

NOMESCO Finland

3.5

10.8

137

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

10.8

280

1804

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.9

10.7

226

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.8

10.7

191

1106

R03BA02

ATC

budesonide; inhalant

1.5

10.7

370

2553

A07AA09

ATC

vancomycin; oral

3.6

10.7

133

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.1

10.5

125

623

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

10.5

381

2657

SPAT1211

SPAT

Application of soft bandage

1.7

10.5

227

1392

K65.0

ICD-10 Finland

Acute peritonitis

3.5

10.5

140

M76.6

ICD-10 Finland

Achilles tendinitis

2.1

10.5

118

575

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

10.1

10.5

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

10.4

169

949

N16.3*M10.0

ICD-10 Finland

Nephropathy caused by gout

+∞

10.4

N30.0

ICD-10 Finland

Acute cystitis

1.6

10.3

268

1727

I49.5

ICD-10 Finland

Sick sinus syndrome

2.0

10.3

124

625

C08CA10

ATC

nilvadipine; oral

2.6

10.3

285

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

4.4

10.3

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.6

10.3

127

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

3.4

10.2

143

R52.9

ICD-10 Finland

Pain, unspecified

1.7

10.2

194

1145

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.8

10.2

178

1022

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.9

10.2

203

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

10.2

288

1897

S22.3

ICD-10 Finland

Fracture of rib

1.8

10.2

190

1116

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

10.2

131

676

RS220

NOMESCO Finland

3.7

10.2

118

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

10.2

455

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.0

10.1

135

705

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

10.1

296

1964

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

10.1

118

586

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

6.2

10.1

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.2

10.1

436

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

10.1

124

629

A10BX07

ATC

[U] liraglutide; parenteral

3.2

10.0

167

NG1AD

NOMESCO Finland

Knee CT examination

4.1

10.0

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

10.0

328

2238

V03AE03

ATC

lanthanum carbonate; oral

7.2

10.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

10.0

244

1549

M11.2

ICD-10 Finland

Other chondrocalcinosis

6.1

10.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

10.0

270

1759

SPAT1325

SPAT

Vaccination

1.3

9.9

945

7793

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.5

9.9

316

S01

ICPC

Pain/tenderness of skin

2.1

9.9

112

551

Z72.1

ICD-10 Finland

Alcohol use

3.7

9.9

116

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

12.2

9.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

9.8

106

508

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

26.1

9.8

J01FA09

ATC

clarithromycin; systemic

1.4

9.8

633

4918

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

3.6

9.8

117

B01AB04

ATC

dalteparin; parenteral

1.9

9.8

136

723

R05FB02

ATC

cough suppressants and expectorants

1.3

9.8

912

7498

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

9.8

221

1373

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

9.7

330

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

9.7

240

1529

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

9.7

322

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

9.6

361

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

9.6

103

494

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.4

9.6

129

D07AD01

ATC

clobetasol; topical

1.5

9.6

338

2340

M09AX01

ATC

hyaluronic acid; parenteral

1.9

9.6

143

779

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

9.6

342

2372

D07AA02

ATC

hydrocortisone; topical

1.6

9.6

274

1807

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

9.6

169

975

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.8

9.6

104

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.6

9.6

255

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

9.6

309

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

9.6

260

1697

D02AE01

ATC

carbamide; topical

1.8

9.6

161

914

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

9.5

111

552

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

10.1

9.5

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.4

9.5

R03AC13

ATC

formoterol; inhalant

2.0

9.5

120

617

L90

ICPC

Osteoarthrosis of knee

1.8

9.5

155

871

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

3.7

9.5

110

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

9.5

180

1063

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.5

788

6365

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

9.4

290

1949

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

9.4

125

653

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.9

9.4

141

770

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

4.6

9.4

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

9.4

154

868

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

9.4

440

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.9

9.3

127

671

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

9.3

1539

13614

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.6

9.3

264

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

3.0

9.3

171

R42

ICD-10 Finland

Dizziness and giddiness

1.4

9.3

544

4152

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

9.3

155

879

C02DE04

ATC

2.1

9.3

102

494

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.4

9.3

321

N06AX21

ATC

duloxetine; oral

1.7

9.2

198

1210

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

9.2

111

559

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

9.2

224

1421

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

4.0

9.2

K92.0

ICD-10 Finland

Haematemesis

2.2

9.2

395

E87.6

ICD-10 Finland

Hypokalaemia

2.3

9.2

363

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

9.1

304

2080

M25.0

ICD-10 Finland

Haemarthrosis

3.5

9.1

119

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

9.1

175

1036

R2110

NOMESCO Finland

Giving the first information

1.9

9.1

129

691

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

9.1

155

886

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.3

9.0

339

E000003

ATC

2.0

9.0

112

571

B81

ICPC

Anaemia vit B12/folate deficiency

2.0

9.0

118

612

C10AB05

ATC

fenofibrate; oral

2.7

9.0

215

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

9.0

1331

11594

J01CF02

ATC

cloxacillin; systemic

2.3

9.0

341

C09DB01

ATC

valsartan and amlodipine; oral

2.1

9.0

100

487

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

9.0

103

511

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.9

9.0

187

A60

ICPC

General and Unspecified, Result test/procedure

2.0

8.9

111

566

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.7

8.9

217

Z01.7

ICD-10 Finland

Laboratory examination

1.6

8.9

247

1617

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.6

8.9

241

1571

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

8.9

126

677

7151

FHL

Kidney transplantation

24.1

8.9

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

3.0

8.9

160

H03AA01

ATC

levothyroxine sodium; systemic

1.4

8.9

427

3151

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

8.8

337

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

4.8

8.8

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.1

8.8

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

8.8

123

657

B03XA01

ATC

erythropoietin; parenteral

3.9

8.8

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.8

8.8

C09BA03

ATC

lisinopril and diuretics; oral

2.3

8.8

350

L08

ICPC

Shoulder symptom/complaint

1.4

8.8

447

3329

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.5

8.8

255

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

8.8

371

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

8.8

912

7582

ZX140

NOMESCO Finland

Intra articular

4.6

8.8

S06.0

ICD-10 Finland

Concussion

1.6

8.8

236

1536

M02AA10

ATC

ketoprofen; topical

1.4

8.8

370

2663

TQW80

NOMESCO Finland

Local dermatologic skincare

2.3

8.7

352

K29

ICPC

Cardiovascular sympt/complt other

1.9

8.7

126

680

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

2.8

8.7

191

E21.2

ICD-10 Finland

Other hyperparathyroidism

7.2

8.7

NH3BG

NOMESCO Finland

MRI of foot

7.2

8.7

ZA7.0

ICD-10 Finland

Ankle and foot

3.9

8.7

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.7

8.7

-1

NOMESCO Finland

1.3

8.7

652

5174

1CX08

NOMESCO Finland

4.9

8.7

P16

ICPC

Acute alcohol abuse

3.1

8.6

152

XF640

NOMESCO Finland

2.1

8.6

447

JN4AD

NOMESCO Finland

Body CT examination

1.6

8.6

224

1444

B82

ICPC

Anaemia other/unspecified

2.3

8.6

327

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

8.6

2235

20835

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.8

8.6

142

804

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.8

8.6

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

8.2

8.6

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

8.5

254

WZC30

NOMESCO Finland

Teaching

1.5

8.5

341

2426

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.8

8.5

130

719

SPAT1202

SPAT

Intra-articular injection

2.1

8.5

457

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.8

8.5

189

TK830

NOMESCO Finland

Ultrafiltration

20.1

8.5

A10BB01

ATC

glibenclamide; oral

1.8

8.4

148

854

WX212

NOMESCO Finland

Femoral plexus blockade

2.6

8.4

224

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.6

8.4

241

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

8.4

413

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

8.4

413

A10BX01

ATC

guar gum; systemic

1.9

8.4

115

608

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.0

8.4

109

567

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.3

8.3

328

S17

ICPC

Abrasion/scratch/blister

2.4

8.3

270

L10

ICPC

Elbow symptom/complaint

2.0

8.3

100

504

A10BG03

ATC

pioglitazone; oral

2.2

8.3

395

R81

ICPC

Pneumonia

2.1

8.3

455

C09DA01

ATC

losartan and diuretics; oral

1.5

8.3

284

1954

A10BK02

ATC

canagliflozin; oral

6.2

8.3

R03DA04

ATC

theophylline; systemic, rectal

1.7

8.3

162

966

R07.3

ICD-10 Finland

Other chest pain

1.6

8.3

235

1549

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.7

8.2

204

K60

ICPC

Cardiovascular, Result test/procedure

3.6

8.2

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.3

8.2

335

SPAT1281

SPAT

Other administrative function

1.6

8.2

193

1213

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

3.2

8.2

130

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.0

8.2

104

538

XX9XE

NOMESCO Finland

Other ultrasound examination

4.9

8.2

EBA00

NOMESCO Finland

Extraction of tooth

1.3

8.2

751

6131

R06.2

ICD-10 Finland

Wheezing

2.0

8.2

503

F10.24

ICD-10 Finland

Alcohol depence active use

3.0

8.1

148

D11

ICPC

Diarrhoea

1.6

8.1

190

1192

M17.5

ICD-10 Finland

Other secondary gonarthrosis

3.2

8.1

126

R5110

SPAT

2.3

8.1

320

J20

ICD-10 Finland

Acute bronchitis

1.6

8.1

204

1305

XF402

NOMESCO Finland

ECG with work load test

1.5

8.0

313

2215

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.9

8.0

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

3.3

8.0

116

NH3AE

NOMESCO Finland

Feet ultrasound examination

10.0

8.0

C09DA07

ATC

telmisartan and diuretics; oral

1.9

8.0

116

627

D05AX02

ATC

calcipotriol; topical

1.9

8.0

112

598

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

8.0

231

1531

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.4

8.0

275

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

8.0

241

1611

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.3

7.9

317

M01AC06

ATC

meloxicam; systemic, rectal

1.3

7.9

807

6675

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

7.9

134

766

-50

ICPC

Medication/prescr/renewal

1.9

7.9

115

625

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.6

7.9

188

1190

M70.3

ICD-10 Finland

Other bursitis of elbow

3.5

7.8

JN4BD

NOMESCO Finland

Extensive body CT

1.5

7.8

303

2142

L04AA13

ATC

leflunomide; oral

2.5

7.8

227

M86.8

ICD-10 Finland

Other osteomyelitis

9.4

7.8

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

4.1

7.8

S22

ICPC

Nail symptom/complaint

1.8

7.8

138

800

RJ411

NOMESCO Finland

5.0

7.7

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

2.8

7.6

172

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

3.6

7.6

ZX108

NOMESCO Finland

Inhalation

3.8

7.6

C02EA05

ATC

3.7

7.6

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

7.6

573

4541

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.9

7.6

103

546

P06

ICPC

Sleep disturbance

1.6

7.6

185

1173

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.4

7.6

252

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.7

7.6

NGS10

NOMESCO Finland

Incision and debridement of infection of knee joint

6.7

7.6

D05BB02

ATC

acitretin; oral

2.3

7.6

303

L09

ICPC

Arm symptom/complaint

2.0

7.6

441

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

8.9

7.5

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

7.5

112

612

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

2.9

7.5

155

R51.80

ICD-10 Finland

Headache

1.5

7.5

246

1676

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

5.4

7.5

C03EA02

ATC

trichlormethiazide and potassium-sparing agents; oral

2.5

7.5

228

S99.9

ICD-10 Finland

Unspecified injury of ankle and foot

3.0

7.5

140

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

4.8

7.4

N05CD07

ATC

temazepam; oral

1.4

7.4

335

2437

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

7.4

194

1254

K22

ICPC

Risk factor cardiovascular disease

1.7

7.4

147

881

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

7.4

121

686

K85

ICPC

Elevated blood pressure

1.4

7.4

374

2779

NGQ20

NOMESCO Finland

Amputation of lower leg

4.2

7.4

C10AA03

ATC

pravastatin; oral

1.6

7.4

212

1401

R06.4

ICD-10 Finland

Hyperventilation

3.2

7.4

113

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.3

7.4

269

N06AA09

ATC

amitriptyline; systemic

1.5

7.4

215

1428

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2.0

7.4

467

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

3.5

7.4

E83.51

ICD-10 Finland

Hypocalcemia

5.6

7.4

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.3

7.3

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

3.1

7.3

125

T14.5

ICD-10 Finland

Injury of blood vessel(s) of unspecified body region

4.7

7.3

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

7.3

396

N16.3*M10.9

ICD-10 Finland

Gout nephropathy

+∞

7.3

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.8

7.3

153

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.2

7.3

316

E78.11

ICD-10 Finland

Other hypertriglyceridemia

4.9

7.3

S81.0

ICD-10 Finland

Open wound of knee

2.9

7.3

137

M86.6

ICD-10 Finland

Other chronic osteomyelitis

5.4

7.2

K08.3

ICD-10 Finland

Retained dental root

1.6

7.2

184

1184

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

2.6

7.2

185

GD1LA

NOMESCO Finland

2.6

7.2

195

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.5

7.2

203

UKC02

NOMESCO Finland

Cystoscopy

1.3

7.2

525

4142

C08CA03

ATC

isradipine; systemic

2.7

7.2

171

M01AB55

ATC

diclofenac, combinations; oral

1.6

7.2

168

1058

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

3.6

7.2

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

7.1

432

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.7

7.1

156

965

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

7.1

156

965

S09

ICPC

Infected finger/toe

2.1

7.1

348

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

7.1

167

1051

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.4

7.1

253

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

12.0

7.1

R60.1

ICD-10 Finland

Generalized oedema

5.3

7.1

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

6.0

7.1

A10BJ01

ATC

exenatide; parenteral

3.6

7.1

L88

ICPC

Rheumatoid/seropositive arthritis

2.0

7.1

398

RF220

NOMESCO Finland

2.6

7.1

181

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

7.0

108

597

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.1

7.0

388

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

7.0

1195

10478

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

7.0

289

2068

162

Kela drug reimbursment

liraglutide

2.9

7.0

145

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

7.0

995

8546

M71.0

ICD-10 Finland

Abscess of bursa

4.0

7.0

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

4.0

7.0

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

7.0

369

2765

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

7.0

172

1097

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

6.9

252

1760

PFH66

NOMESCO Finland

Bypass from femoral or popliteal artery to dorsal artery of foot

6.3

6.9

QD6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in foot

6.3

6.9

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

6.9

229

1567

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

3.0

6.9

119

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.0

6.9

422

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.4

6.9

221

C09AA01

ATC

captopril; oral

2.2

6.9

313

XG405

NOMESCO Finland

Education on PEF monitoring

2.8

6.9

154

UJD02

NOMESCO Finland

Gastroscopy

1.7

6.9

125

733

B60

ICPC

Blood and Immunity, Result test/procedure

2.8

6.9

148

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

6.8

453

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.5

6.8

197

R52.0

ICD-10 Finland

Acute pain

2.2

6.8

319

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.1

6.8

366

A11

ICPC

Chest pain NOS

1.6

6.8

183

1193

J01FA15

ATC

telithromycin; oral

1.5

6.8

195

1290

I13.1

ICD-10 Finland

Hypertensive heart and renal disease with renal failure

9.3

6.8

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

3.0

6.8

121

B01AE07

ATC

dabigatran etexilate; oral

1.8

6.8

117

676

A62

ICPC

General and Unspecified, Administrative procedure

2.2

6.7

301

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

3.2

6.7

105

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.2

6.7

105

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.0

6.7

425

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.0

6.7

440

AP1

Catheterization of the left side of the heart

2.3

6.7

261

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.7

6.7

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

6.7

1173

10303

D64.8

ICD-10 Finland

Other specified anaemias

2.5

6.6

205

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

2.9

6.6

132

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

6.6

735

6127

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

6.6

167

1073

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

7.8

6.6

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.4

6.6

224

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

6.6

340

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

6.6

459

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

6.6

114

660

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

5.5

6.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

6.6

380

A10BG02

ATC

rosiglitazone; oral

2.4

6.6

214

N03.0

ICD-10 Finland

Chronic nephritic syndrome, minor glomerular abnormality

12.3

6.6

7910X

ICD-9 Finland

Nonspecific findings on examination of urine, Proteinuria[PROTEINURIA NUD]

12.3

6.6

SPAT1167

SPAT

Insertion of urinary catheter

1.8

6.6

108

614

K11.2

ICD-10 Finland

Sialoadenitis

2.2

6.6

298

I95.1

ICD-10 Finland

Orthostatic hypotension

1.8

6.6

108

615

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

6.6

1102

9630

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

8.7

6.5

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

2.1

6.5

359

SPAT1097

SPAT

Recording of ECG

1.4

6.5

397

3042

C02EA03

ATC

2.5

6.5

200

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

5.0

6.5

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

6.5

105

593

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

4.0

6.5

N06AB04

ATC

citalopram; systemic

1.3

6.5

441

3438

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.3

6.5

229

K48

ICPC

Cardiovascular, Clarification/discussion RFE/demand

5.3

6.4

Z00.0

ICD-10 Finland

General medical examination

1.3

6.4

426

3307

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.1

6.4

103

JKA20

NOMESCO Finland

Cholecystectomy

1.9

6.4

486

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

6.4

148

930

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

2.0

6.4

418

N16.2*D86.8

ICD-10 Finland

Renal tubulo-interstitial disorders in sarcoidosis

70.0

6.4

L20.0

ICD-10 Finland

Besnier prurigo

2.0

6.4

419

H25.8

ICD-10 Finland

Other senile cataract

1.4

6.4

309

2275

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

6.4

1056

9198

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.0

6.4

109

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.7

6.4

131

797

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

6.4

275

SPAT1240

SPAT

Therapeutic discussion

1.6

6.4

147

922

R24

ICPC

Haemoptysis

3.6

6.4

Z08

ICPC

Social welfare problem

3.3

6.3

Z29

ICPC

Social problem NOS

2.6

6.3

162

WX704

NOMESCO Finland

Intubation

1.6

6.3

164

1061

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

8.2

6.3

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.3

410

3172

SPAT1251

SPAT

Organisation of medication

1.8

6.3

546

ACC51

NOMESCO Finland

Release of median nerve

1.6

6.3

145

911

RS222

NOMESCO Finland

3.1

6.3

105

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

9.3

6.3

J96.1

ICD-10 Finland

Chronic respiratory failure

2.0

6.3

352

187

Kela drug reimbursment

MPA

+∞

6.2

J94.8

ICD-10 Finland

Other specified pleural conditions

2.3

6.2

227

SPAT1104

SPAT

Monitoring of emergency patient

1.6

6.2

169

1104

I20.01

ICD-10 Finland

Unstable angina

1.8

6.2

101

572

WX730

NOMESCO Finland

Conventional respirator

2.4

6.2

202

M03BX02

ATC

tizanidine; oral

1.2

6.2

1323

11830

SPAT1060

SPAT

Administration of oxygen

4.5

6.1

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

6.1

536

4325

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

5.3

6.1

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

6.1

432

3384

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

5.7

6.1

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

6.1

442

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

6.1

208

1433

K90

ICPC

Stroke/cerebrovascular accident

1.9

6.1

457

D10

ICPC

Vomiting

2.0

6.1

336

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.1

6.1

310

D01AC03

ATC

econazole; topical

1.6

6.1

162

1056

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

6.1

387

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

2.5

6.1

178

C07FB02

ATC

metoprolol and felodipine; systemic

1.9

6.1

459

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

4.0

6.1

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

12.5

6.1

5AB14

NOMESCO Finland

12.5

6.1

H28.0*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic cataract

8.6

6.0

C10AB04

ATC

gemfibrozil; oral

2.6

6.0

154

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.0

6.0

366

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

6.0

221

1545

WX610

NOMESCO Finland

Patient controlled analgesia

4.9

6.0

N05CF02

ATC

zolpidem; oral

1.4

6.0

331

2495

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.9

6.0

422

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.8

6.0

131

M15

ICD-10 Finland

Polyarthrosis

1.8

6.0

101

577

S10

ICPC

Boil/carbuncle

1.7

6.0

127

779

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

615

667

11.08

307.65

1.6

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2557

7340

11.62

307.65

5.6

2.6

umol/l

3362.2

6376.9

2.82

2338

6236

(3000475) Leukocytes [#/volume] in Synovial fluid

427

620

7.75

285.22

1.8

1.6

e6/l

18826.4

15199.2

0.46

331

441

(3020779) Urea [Moles/volume] in Serum or Plasma

907

2891

3.93

244.66

12.3

6.8

mmol/l

14.4

10.6

33.53

868

2732

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1073

3868

3.61

240.35

11.2

5.8

mmol/l

1.1

1.0

15.08

1010

3590

(3042936) Bacteria identified in Isolate by Culture

1094

4096

3.49

229.48

2.5

2.0

—

(3021788) Differential panel - Synovial fluid

314

455

7.51

208.66

1.6

1.5

—

(3023368) Bacteria identified in Blood by Culture

1728

8986

2.91

198.18

6.7

4.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1078

4364

3.17

194.08

4.6

2.5

g/l

2.2

2.3

4.07

1011

4044

(3044941) Cell count panel - Synovial fluid

281

398

7.62

190.26

1.6

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

882

3225

3.36

187.56

1.4

1.2

u/ml

15.3

15.0

0.04

291

1171

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1028

4120

3.16

187.39

4.7

2.5

21.4

22.8

2.15

889

3486

(3022948) Iron [Moles/volume] in Serum or Plasma

1110

4674

3.06

185.26

4.6

2.5

umol/l

11.3

12.7

9.24

1048

4320

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

891

3438

3.17

171.47

1.4

1.2

iu/ml

36.5

37.9

0.09

304

1025

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

628

1961

3.71

169.44

7.6

3.8

ng/l

156.4

97.1

16.38

556

1672

(3006315) Basophils [#/volume] in Blood

2131

13135

2.72

164.03

7.5

5.5

e9/l

0.0

0.16

1872

11239

(3001604) Monocytes [#/volume] in Blood

2118

13060

2.70

162.12

7.4

5.5

e9/l

0.7

0.6

8.69

1859

11152

(3013115) Eosinophils [#/volume] in Blood

2171

13562

2.72

161.65

7.9

5.7

e9/l

0.2

0.79

1925

11749

(3022096) Basophils/100 leukocytes in Blood

1987

11948

2.64

158.92

7.9

5.9

0.6

0.7

3.57

1893

11074

(3006504) Eosinophils/100 leukocytes in Blood

2021

12301

2.63

156.80

7.9

5.9

2.7

2.9

3.33

1928

11389

(3019069) Monocytes/100 leukocytes in Blood

2024

12362

2.62

155.34

8.2

6.2

8.9

9.1

1.69

1929

11490

(3019198) Lymphocytes [#/volume] in Blood

2132

13367

2.65

154.65

7.7

5.6

e9/l

1.8

1.9

2.28

1902

11611

(3002030) Lymphocytes/100 leukocytes in Blood

2030

12590

2.56

148.01

8.1

6.0

23.1

26.0

29.25

1924

11610

(42870588) Differential panel, method unspecified - Blood

1643

9240

2.53

147.89

7.4

5.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2304

15211

2.66

146.61

10.3

8.7

e9/l

4.9

4.3

22.31

2037

13173

(3010144) Erythrocytes [#/volume] in Synovial fluid

194

244

8.38

144.90

1.5

1.3

e6/l

27735.5

138687.7

1.57

134

172

(3018010) Neutrophils/100 leukocytes in Blood

2000

12399

2.53

144.64

7.7

5.8

61.6

58.5

27.24

1904

11498

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

213

303

7.44

143.12

1.6

1.5

74.3

60.9

4.62

152

194

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2189

14315

2.54

138.44

13.2

7.0

mmol/l

1.2

0.72

1896

12022

(3009508) Creatinine [Moles/volume] in Urine

1641

9474

2.44

136.07

4.4

3.2

mmol/l

7.2

7.9

11.57

1433

7840

(3012516) Albumin [Mass/volume] in Urine

1611

9301

2.41

132.55

4.4

3.2

mg/l

315.9

289.2

0.12

1218

6171

(3020682) Albumin/Creatinine [Ratio] in Urine

1672

9837

2.40

131.47

5.4

4.0

mg/mmol

24.4

8.5

13.55

1252

6497

(3021447) Carbon dioxide [Partial pressure] in Venous blood

749

3057

2.87

126.25

7.7

3.5

kpa

5.9

5.8

0.91

728

2965

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2012

13035

2.37

124.02

12.4

6.2

mmol/l

1.2

0.05

1891

11739

(3002032) Base excess in Venous blood by calculation

745

3060

2.85

123.87

7.7

3.5

mmol/l

1.5

2.0

2.73

617

2426

(3037522) Nuclear Ab [Titer] in Serum

710

2861

2.88

122.20

1.3

titre

415.4

474.8

0.39

143

596

(3024561) Albumin [Mass/volume] in Serum or Plasma

1954

12553

2.34

122.08

7.8

4.9

g/l

33.6

34.7

13.96

1843

11627

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

461

1463

3.50

119.01

8.4

3.6

mmol/l

23.5

24.1

3.29

416

1303

(3000991) Gas panel - Venous blood

661

2667

2.84

112.70

12.5

8.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1024

5151

2.43

110.70

2.4

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1320

7412

2.29

110.55

2.9

2.2

mg/l

3.2

3.0

2.62

1156

6258

(3018418) pH of Serum or Plasma

1437

8360

2.26

110.44

8.3

4.0

7.4

0.95

269

1631

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1611

9833

2.23

109.87

4.7

3.1

ng/l

3040.6

1640.4

12.74

1445

8563

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2139

14666

2.28

108.99

7.4

6.4

umol/l

13.0

12.6

0.61

2049

13954

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1644

10153

2.22

108.45

4.7

2.7

ug/l

229.5

178.6

2.75

1528

9194

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

163

243

7.00

104.66

1.6

1.4

16.6

25.6

2.86

117

150

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

318

864

3.96

102.77

1.8

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

769

3550

2.52

98.83

2.2

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2348

17080

2.26

98.48

8.3

5.1

mmol/l

7.2

6.9

5.85

2263

16149

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

762

3533

2.50

96.80

2.2

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

944

4829

2.33

96.08

4.4

3.2

mmol/l

0.8

8.10

898

4510

(3020630) Protein [Mass/volume] in Serum or Plasma

620

2658

2.64

92.38

2.3

2.6

g/l

64.9

66.2

3.79

569

2405

(3013707) Erythrocyte sedimentation rate by Westergren method

2542

19400

2.30

90.37

6.3

4.0

mm/h

21.7

13.1

71.10

2406

17758

(3018095) Leukocytes [#/volume] in Urine

1596

10229

2.07

90.20

6.0

3.9

e6/l

52.0

106.3

4.25

1272

7675

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2692

21095

2.43

89.19

11.5

7.7

u/l

87.5

79.5

8.86

2594

19823

(3032080) INR in Blood by Coagulation assay

1905

13072

2.07

88.75

18.4

10.7

inr

1.4

2.13

534

3592

(3002582) Erythrocytes [#/volume] in Urine

1470

9181

2.07

88.70

5.1

3.5

e6/l

54.2

100.7

1.85

1234

7237

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

428

1548

3.02

87.74

1.8

1.7

g/l

1.7

1.5

3.99

384

1332

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

364

1197

3.29

87.72

3.7

2.7

u/ml

0.3

0.28

214

668

(3007853) Bacteria identified in Skin by Aerobe culture

702

3273

2.45

87.15

2.5

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1535

9896

2.02

83.27

2.9

2.1

nmol/l

74.5

77.5

3.70

1387

8632

(3014111) Lactate [Moles/volume] in Serum or Plasma

633

2875

2.48

82.82

9.5

7.1

mmol/l

1.4

0.15

601

2762

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

755

3711

2.34

82.73

3.5

4.1

u/l

240.7

242.4

0.12

706

3509

(3004588) Protein electrophoresis panel - Serum or Plasma

531

2218

2.66

82.73

2.1

2.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

876

4616

2.22

81.01

34.4

28.3

inr

1.5

1.4

0.85

115

652

(3031040) Bacteria [#/volume] in Urine by Automated count

2356

17816

2.10

80.04

6.3

4.6

e6/l

726.1

1526.8

0.68

317

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

994

5531

2.14

79.86

1.9

1.7

mg/l

1.4

1.5

0.39

801

4350

(3027801) Oxygen [Partial pressure] in Arterial blood

771

3880

2.28

79.57

8.6

7.4

kpa

11.3

11.9

2.90

739

3694

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

771

3880

2.28

79.57

8.6

7.4

kpa

5.0

5.1

0.65

740

3691

(3037467) Urinalysis macro (dipstick) panel - Urine

2410

18403

2.11

79.40

6.4

4.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

769

3872

2.28

79.22

2.9

2.3

1.9

1.7

6.61

679

3399

(3024354) Oxygen [Partial pressure] in Venous blood

567

2509

2.52

78.09

5.9

2.9

kpa

4.9

4.5

2.61

546

2426

(40758558) Short blood count panel - Blood

1121

6572

2.06

78.00

7.8

6.6

—

(3003396) Base excess in Arterial blood by calculation

765

3877

2.26

77.38

8.5

7.4

mmol/l

0.6

1.1

1.93

604

2996

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

502

2118

2.61

76.25

2.0

1.6

—

(3024263) Appearance of Synovial fluid

109

150

7.48

75.10

1.9

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

350

1235

3.05

74.46

1.4

1.6

u/ml

15.2

21.1

—

(36304419) Bacteria [Presence] in Urine

1280

7978

1.98

74.12

4.8

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1321

8347

1.96

73.30

4.9

3.4

e6/l

0.6

0.5

0.84

1068

6417

(3000850) Epithelial cells [#/volume] in Urine

1091

6455

2.03

73.07

3.9

2.7

e6/l

4.0

3.9

0.10

986

5677

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

314

1066

3.15

71.31

2.2

3.4

mg/l

41.2

63.9

1.05

248

865

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1313

8351

1.94

70.84

3.9

3.3

u/l

35.4

39.2

0.82

1245

7887

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

308

1040

3.16

70.57

2.2

3.4

ratio

1.7

2.8

0.77

(3034860) Kappa light chains.free [Mass/volume] in Serum

313

1067

3.13

70.56

2.2

3.4

mg/l

65.3

59.6

0.24

246

861

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1735

12125

1.90

69.91

2.5

2.1

pmol/l

86.7

92.3

6.00

1032

6664

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1386

9008

1.92

69.80

2.6

2.2

u/l

210.5

249.3

0.76

1309

8416

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

486

2109

2.53

69.22

5.3

3.5

kpa

5.1

0.25

451

1933

(3016502) Oxygen saturation in Arterial blood

695

3531

2.22

69.01

8.9

7.7

94.5

95.4

2.24

675

3398

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

239

708

3.56

67.50

4.1

2.7

mg/l

2.3

1.6

15.54

223

633

(3009343) pH of Capillary blood

475

2076

2.50

66.48

5.3

3.6

7.4

0.90

258

(3023520) Reticulocytes [#/volume] in Blood

604

2937

2.29

66.45

3.0

2.4

e9/l

73.4

67.2

3.55

441

2254

(3033658) Prothrombin time (PT) actual/Normal

1146

7087

1.94

66.19

6.5

4.2

80.4

83.3

2.86

1118

6952

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

460

2001

2.51

64.95

5.2

3.5

mmol/l

2.0

1.8

0.36

322

1457

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1339

8766

1.88

64.57

3.3

2.6

u/l

56.8

58.5

0.79

1269

8096

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1009

6020

1.97

64.45

5.5

4.1

ng/l

656.4

654.5

0.00

906

5202

(3018677) aPTT in Platelet poor plasma by Coagulation assay

874

4961

2.03

64.33

2.5

2.0

31.0

30.2

2.93

857

4815

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

317

1155

2.93

63.38

2.0

2.3

g/l

3.3

3.1

3.03

251

908

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

279

958

3.09

61.93

1.6

1.5

titre

120.0

237.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

364

1450

2.70

61.41

2.4

1.9

ug/l

1.3

2.4

1.35

323

1264

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

294

1049

2.98

60.98

2.1

2.4

g/l

0.5

1.2

3.16

248

895

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

327

1262

2.76

58.59

2.1

2.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

267

923

3.06

58.51

2.0

2.3

g/l

0.0

0.97

243

834

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

327

1263

2.76

58.50

2.1

2.3

g/l

7.9

7.4

4.92

255

923

(3014576) Chloride [Moles/volume] in Serum or Plasma

748

4138

2.04

58.38

10.3

7.0

mmol/l

104.6

104.5

0.43

733

4028

(3021960) Folate [Moles/volume] in Serum or Plasma

1130

7184

1.87

58.36

1.9

1.6

nmol/l

19.1

19.6

0.36

1015

6090

(3026008) Bacteria identified in Urine by Culture

1228

8013

1.84

58.33

3.8

3.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

326

1260

2.76

58.23

2.1

2.3

g/l

4.0

3.8

1.13

249

890

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

585

2969

2.18

57.24

3.9

2.9

ng/l

401.1

219.7

5.91

544

2731

(3035350) Ketones [Presence] in Urine by Test strip

1762

12859

1.78

57.12

5.0

3.7

estimate

0.0

0.50

377

2414

(3026782) Osmolality of Urine

986

6038

1.90

56.99

4.2

2.9

mosm/kgh2o

522.8

573.3

11.54

871

5151

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

407

1779

2.47

56.47

9.8

9.7

mmol/l

23.9

24.3

1.29

383

1652

(3009261) Glucose [Presence] in Urine by Test strip

1773

12992

1.78

56.39

5.1

3.7

estimate

0.0

0.30

365

2329

(3044640) Blood type and Crossmatch panel - Blood

1319

8872

1.80

56.15

3.7

2.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

616

3212

2.13

56.13

9.6

8.2

g/l

118.2

122.0

3.78

602

3092

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

270

964

2.96

55.83

2.0

2.2

g/l

35.8

37.5

3.85

230

823

(3019309) Folate [Moles/volume] in Red Blood Cells

986

6080

1.88

55.51

2.0

1.8

nmol/l

1182.8

1165.8

0.22

771

4535

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

295

1109

2.82

55.48

2.6

2.2

ug/l

398.2

509.7

0.60

286

1049

(3026250) Tacrolimus [Mass/volume] in Blood

8.11

55.05

36.4

31.5

ug/l

7.0

7.2

0.41

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2985

25970

2.41

54.54

36.0

16.5

mg/l

30.1

28.0

2.91

2801

21163

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

825

4839

1.94

53.86

4.2

3.2

e6/l

1.8

1.3

1.11

472

2787

(3021601) Nitrite [Presence] in Urine by Test strip

1743

12820

1.75

53.68

6.6

4.9

estimate

0.0

0.00

392

2450

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

304

1185

2.72

53.28

2.1

2.3

g/l

9.3

10.4

5.53

258

1000

(3021589) Normoblasts [#/volume] in Blood

1603

11536

1.75

53.14

15.4

10.3

e9/l

0.0

0.28

1312

9447

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1739

12822

1.74

52.73

5.8

4.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

253

899

2.96

52.71

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

246

863

3.00

52.43

2.1

2.3

g/l

0.0

0.50

222

777

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

9.84

51.92

1.5

1.3

21.9

33.3

1.30

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

240

846

2.98

50.69

2.1

2.3

g/l

0.0

0.00

221

774

(40768446) Kidney Pathology biopsy report

7.58

49.23

2.0

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

450

2180

2.23

48.91

2.3

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

228

799

2.99

48.63

2.1

3.5

—

(3024928) Oxygen saturation in Venous blood

205

677

3.16

48.44

5.4

3.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

418

1978

2.27

48.04

2.1

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

150

408

3.80

47.91

6.1

3.7

—

(3037756) Immunofixation for Serum or Plasma

207

694

3.11

47.67

1.3

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

578

3121

2.03

47.23

3.1

2.9

umol/l

9.4

9.5

0.04

506

2770

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1602

11780

1.69

47.04

6.1

4.0

ng/l

53.7

58.4

0.26

1321

9126

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

840

5146

1.84

47.00

3.9

3.0

e6/l

1.1

0.10

483

3062

(3015736) pH of Urine

1405

9997

1.70

46.51

4.4

3.5

—

5.9

—

(3019060) Gas panel - Arterial blood

459

2305

2.15

45.40

5.3

4.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

511

2682

2.07

44.96

2.2

g/l

0.2

0.90

469

2487

(3010375) cycloSPORINE [Mass/volume] in Blood

7.18

44.92

26.2

27.6

ug/l

94.9

124.9

1.69

(3028626) Oxygen [Partial pressure] in Capillary blood

217

773

2.93

44.90

3.8

3.0

kpa

8.0

7.9

0.53

201

711

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

450

2256

2.15

44.66

2.2

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1031

6828

1.74

43.73

3.7

2.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

171

540

3.28

43.48

6.3

5.3

iu/ml

640.9

3499.1

0.49

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

12.09

42.82

13.5

11.3

mmol/l

5.1

5.8

0.72

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

187

632

3.08

42.43

1.5

1.3

g/l

0.3

0.2

2.33

181

597

(3011397) Hemoglobin [Presence] in Urine by Test strip

944

6154

1.74

42.05

4.5

3.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

190

653

3.02

41.87

1.5

1.4

g/l

1.2

2.80

185

616

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2025

16123

1.65

41.42

4.5

3.2

u/l

89.7

56.5

17.14

1897

14772

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

383

1854

2.20

41.37

1.9

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

503

2702

2.01

41.27

2.1

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

232

901

2.69

40.74

4.0

3.3

mmol/l

23.9

24.9

1.85

202

768

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

472

2489

2.04

40.74

2.9

2.5

u/l

64.7

36.4

0.50

411

2112

(3013166) Neutrophils/100 leukocytes in Synovial fluid

7.04

40.26

1.7

1.1

64.1

61.9

0.14

(3028026) IgM [Mass/volume] in Serum or Plasma

323

1483

2.30

39.58

1.6

1.8

g/l

1.3

1.4

0.35

306

1335

(3005719) IgG [Mass/volume] in Serum or Plasma

383

1897

2.15

38.95

2.3

2.7

g/l

10.1

10.7

1.82

361

1718

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

139

415

3.45

38.62

3.4

2.6

u/ml

111.2

1635.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1286

9262

1.63

38.50

3.9

3.4

mmol/l

2.3

0.01

1118

7959

(3004119) Hemoglobin [Mass/volume] in Venous blood

407

2073

2.10

38.46

6.0

3.3

g/l

122.7

128.8

5.19

398

2022

(3022313) Gas panel - Capillary blood

323

1503

2.27

38.30

5.6

3.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2817

24772

1.88

37.65

8.9

6.5

mmol/mol

42.7

41.0

16.59

2665

22626

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

168

581

2.99

36.60

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

190

703

2.81

36.59

3.1

3.0

nmol/l

0.9

0.8

0.94

157

527

(3042733) HLA Ab [Presence] in Serum

7.53

36.49

6.3

5.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

138

427

3.33

36.25

5.5

6.7

mg/l

11.8

12.0

0.20

125

394

(3035947) Staphylolysin Ab [Units/volume] in Serum

138

5.31

35.77

1.1

1.2

iu/ml

3.6

4.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

175

631

2.87

35.35

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

175

631

2.87

35.35

1.5

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

186

698

2.76

34.86

2.3

2.7

umol/l

32.2

35.4

0.81

158

572

(3052851) Hemolysis interference index of Serum or Plasma

209

839

2.59

34.28

4.3

3.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

478

2684

1.91

34.03

2.1

1.8

1.6

3.42

398

2282

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

532

3112

1.84

33.28

3.0

2.4

ug/l

5.5

7.5

2.00

455

2723

(3021901) Oxygen saturation in Capillary blood

178

671

2.75

33.07

3.7

2.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

807

5331

1.68

32.92

5.9

4.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

243

3.95

32.28

1.1

u/ml

—

(3017181) Myelocytes/100 leukocytes in Blood

427

2354

1.93

32.01

4.7

4.2

1.1

0.9

0.67

140

733

(1616796) Gas panel - Central venous blood

190

756

2.60

31.71

5.7

3.8

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

116

5.43

31.64

1.6

1.4

4.4

3.4

0.31

(3002179) Metamyelocytes/100 leukocytes in Blood

394

2123

1.97

31.57

4.3

4.0

0.8

0.6

0.98

100

526

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2625

23019

1.66

30.38

4.8

4.3

mu/l

2.1

2.2

0.17

2424

20561

(3021440) Promyelocytes/100 leukocytes in Blood

404

2225

1.93

30.30

4.8

4.2

0.1

0.05

129

683

(3021879) Hepatitis B virus core Ab [Presence] in Serum

286

1390

2.16

30.28

1.7

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

351

1854

2.00

29.70

11.3

10.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.76

29.56

5.1

6.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

309

1563

2.08

29.45

6.0

2.5

0.7

0.08

304

1495

(3027273) Bicarbonate [Moles/volume] in Venous blood

325

1678

2.04

29.30

6.0

3.4

mmol/l

24.6

25.1

1.18

319

1627

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

153

572

2.76

28.88

1.7

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

119

388

3.14

28.71

2.2

1.5

u/ml

129.1

119.9

0.32

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2155

18162

1.53

28.53

3.7

3.5

pmol/l

14.9

15.0

1.32

1965

16119

(3019550) Sodium [Moles/volume] in Serum or Plasma

3007

27528

1.93

28.32

42.0

19.8

mmol/l

139.6

0.10

2972

26843

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

262

1264

2.16

28.23

6.2

3.7

mmol/l

24.5

24.8

0.63

236

1156

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

180

740

2.51

28.07

1.6

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

116

379

3.13

27.89

1.5

1.2

u/ml

280.8

292.8

0.17

227

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1603

12755

1.49

27.69

2.7

2.3

—

(3025159) Blasts/100 leukocytes in Blood

375

2076

1.91

27.57

4.8

4.2

0.8

0.3

0.29

108

562

(3023103) Potassium [Moles/volume] in Serum or Plasma

3008

27589

1.91

27.44

42.7

20.0

mmol/l

4.1

4.0

13.48

2967

26863

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

128

456

2.88

26.45

2.3

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

120

416

2.95

26.05

1.4

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

127

455

2.86

25.97

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

2391

20782

1.53

25.90

39.9

20.2

14.6

13.8

64.29

2358

20276

(3008152) Bicarbonate [Moles/volume] in Arterial blood

380

2171

1.85

25.24

9.2

7.0

mmol/l

23.8

24.5

2.81

365

2025

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

223

1061

2.18

24.84

1.9

1.7

u/l

36.4

38.4

0.71

187

902

(3037121) Protein [Mass/volume] in Urine

213

997

2.21

24.71

4.0

3.0

g/l

0.4

0.3

1.15

116

437

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

148

4.32

24.62

1.4

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

145

575

2.59

24.37

1.4

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.41

24.35

1.1

1.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

880

6313

1.53

24.23

1.8

1.7

pmol/l

23809963.0

27150795.1

0.08

735

5127

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

103

5.01

23.94

2.6

2.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2995

27640

1.81

23.83

17.3

11.0

u/l

28.6

27.3

1.87

2935

26476

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

238

1181

2.09

23.79

2.7

—

(40768797) Stomach Pathology biopsy report

559

3629

1.65

23.49

1.2

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

134

521

2.64

23.45

1.4

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

108

376

2.93

23.29

1.3

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

328

3.08

23.28

1.3

2.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

6.12

23.28

1.1

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

155

650

2.45

23.17

2.2

1.8

mg/l

13.5

11.2

2.26

141

600

(3007164) IgA [Mass/volume] in Serum or Plasma

605

4027

1.61

22.94

1.5

g/l

3.0

2.8

1.45

404

2394

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

502

3196

1.67

22.69

5.2

3.6

—

(3024932) HLA-DR beta [Type]

5.75

22.41

1.0

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

169

749

2.32

22.33

1.3

1.2

u/ml

1.2

0.8

0.14

(3006184) Hemoglobin [Mass/volume] in Capillary blood

165

724

2.35

22.31

2.6

2.2

g/l

126.8

128.8

0.39

125

525

(3029937) Albumin [Presence] in Urine by Test strip

974

7239

1.49

22.31

5.5

4.0

estimate

0.0

0.46

347

2279

(3024471) HLA-A [Type]

5.67

22.09

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

150

637

2.42

21.83

1.1

1.2

titre

81.8

99.1

0.26

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

236

3.36

21.31

1.2

u/l

58.5

60.0

0.06

157

(3003434) Protein [Mass/volume] in Pleural fluid

132

536

2.52

21.15

1.7

1.5

g/l

28.2

32.4

3.79

119

482

(3044889) 12 lead EKG panel

2226

19391

1.44

21.11

5.5

4.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

5.05

20.91

1.3

1.2

g/l

34.9

40.8

1.03

(3034770) Mitochondria Ab [Titer] in Serum

149

645

2.37

20.78

1.1

1.2

—

987.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

103

373

2.82

20.70

1.3

—

(3000494) Fungus identified in Specimen by Culture

489

3172

1.63

20.40

1.6

1.5

—

(3008898) HLA-B27 [Presence]

128

523

2.51

20.25

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

166

766

2.23

19.94

2.3

2.4

g/l

4.0

3.6

2.01

160

729

(3023199) Leukocytes [#/volume] in Pleural fluid

118

469

2.57

19.78

1.8

1.5

e6/l

2479.4

1778.5

0.29

346

(40761511) CBC panel - Blood by Automated count

2892

26705

1.62

19.54

30.7

16.0

—

(3011648) Oxygen content in Venous blood

245

3.19

19.43

3.1

1.9

10.5

11.0

0.46

245

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

166

775

2.20

19.39

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

158

724

2.24

19.31

1.8

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

363

2209

1.72

19.26

2.0

2.3

nmol/l

337.9

374.0

2.96

325

2017

(3025941) Bacteria identified in Stool by Culture

231

1224

1.95

19.21

1.4

1.3

—

(3012501) Base excess in Blood by calculation

159

733

2.23

19.15

6.4

4.7

mmol/l

2.6

0.01

110

485

(3012441) Differential panel - Pleural fluid

107

413

2.64

19.04

1.7

1.5

—

(3010421) pH of Blood

177

859

2.12

18.74

6.7

4.6

7.4

0.37

156

719

(3025315) Body weight

10.06

18.48

4.6

4.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

103

4.41

18.23

1.2

1.1

iu/ml

359.4

210.7

0.82

103

(40767503) Oxygen content in Capillary blood by calculation

154

717

2.20

18.12

3.6

2.5

15.9

16.1

0.24

104

371

(3036489) Thrombin time

189

956

2.04

17.92

2.1

2.0

23.3

21.7

1.03

179

863

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

149

694

2.20

17.52

1.7

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

152

714

2.18

17.50

1.6

iu/ml

35.4

6.3

0.38

159

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2688

24576

1.48

17.38

32.8

15.9

ml/min/173m2

63.5

75.5

107.14

2378

20493

(3012565) Volume of 24 hour Urine

140

3.76

16.98

2.7

2.6

1818.0

1949.3

0.44

121

(3018405) Lactate [Moles/volume] in Arterial blood

222

1210

1.89

16.96

5.1

4.0

mmol/l

1.6

1.4

0.84

217

1189

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

199

3.26

16.81

1.1

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

199

3.26

16.81

1.6

1.2

iu/ml

26.7

26.8

—

(3007461) Platelets [#/volume] in Blood

3028

28478

1.68

16.70

48.3

24.3

e9/l

229.3

234.7

4.39

2966

27640

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2832

26226

1.53

16.66

6.2

5.3

mmol/l

2.3

2.6

51.89

2649

23753

(3035941) MCH [Entitic mass]

3028

28482

1.68

16.64

48.1

24.1

30.7

30.6

3.46

3001

27975

(3024731) MCV [Entitic volume]

3028

28483

1.68

16.63

48.2

24.2

92.9

91.6

36.06

3001

27975

(3026361) Erythrocytes [#/volume] in Blood

3028

28484

1.68

16.61

48.3

24.2

e12/l

4.3

4.5

56.81

2956

27548

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

206

3.20

16.55

2.1

2.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

3028

28489

1.68

16.54

48.7

24.4

g/l

130.1

136.2

62.83

3001

27979

(3010813) Leukocytes [#/volume] in Blood

3028

28491

1.68

16.51

48.4

24.3

e9/l

7.7

6.9

31.87

2959

27551

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

367

2330

1.65

16.51

3.6

2.8

ml/min/173m2

44.8

63.0

18.96

193

945

(3028308) Erythrocytes [#/volume] in Pleural fluid

104

427

2.48

16.34

1.7

1.4

e6/l

31939.7

69055.3

0.99

267

(3036782) Glucose [Moles/volume] in Pleural fluid

380

2.57

16.28

1.6

1.4

mmol/l

6.1

6.4

0.54

353

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

719

5315

1.45

16.08

3.3

3.2

mmol/l

2.5

6.74

615

4655

(3045788) Cell count panel - Pleural fluid

368

2.57

15.79

1.8

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2674

24548

1.45

15.77

4.9

4.2

mmol/l

1.7

1.3

71.14

2473

22014

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1228

9979

1.36

15.71

5.4

4.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

376

2.54

15.62

1.5

1.3

u/l

288.1

363.4

0.50

361

(40768806) Pleura Pathology biopsy report

100

412

2.47

15.61

1.9

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2772

25641

1.48

15.54

6.0

5.0

mmol/l

6.4

6.1

25.56

2575

22943

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

236

1348

1.81

15.53

2.5

1.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

141

675

2.14

15.50

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2743

25332

1.46

15.40

5.4

4.7

mmol/l

1.2

1.4

73.72

2564

22886

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

139

3.56

14.87

1.4

1.3

u/l

114.9

96.6

0.44

119

(3014148) Varicella zoster virus Ab [Titer] in Serum

179

3.22

14.77

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2759

25566

1.46

14.67

5.5

4.8

mmol/l

4.1

4.4

37.57

2593

23289

(3043409) Potassium [Moles/volume] in Arterial blood

189

1026

1.89

14.63

5.6

4.2

mmol/l

4.0

3.9

0.36

180

948

(40761535) Cells panel - Urine sediment

381

2518

1.58

14.46

4.7

3.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

218

1244

1.80

14.39

2.3

1.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

194

3.08

14.18

1.2

1.1

titre

62.0

117.7

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

194

3.08

14.18

1.2

1.1

—

134.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

163

852

1.96

14.13

2.4

2.3

ug/min

164.6

102.9

0.79

107

516

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

117

540

2.21

14.12

1.2

u/ml

3.2

6.8

0.87

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

290

2.66

13.92

1.4

1.3

u/l

10.0

14.3

1.55

267

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

101

445

2.31

13.63

1.2

u/ml

1.4

10.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

115

536

2.19

13.56

1.2

u/ml

44.9

3.0

0.66

(3004809) Band form neutrophils/100 leukocytes in Blood

112

519

2.20

13.40

4.3

3.8

1.2

1.7

0.86

391

(3047181) Lactate [Moles/volume] in Blood

189

1058

1.83

13.30

6.9

6.2

mmol/l

1.4

1.3

0.80

174

930

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

321

2.53

13.26

3.1

2.8

—

(3036603) Volume of Urine

181

3.07

13.22

1.5

1.8

2106.3

1828.8

—

(3047189) Immunofixation for 24 hour Urine

156

3.24

13.13

1.3

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

123

602

2.08

12.81

1.5

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

414

2.31

12.72

1.2

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

140

3.32

12.58

1.6

u/l

15.8

7.7

0.66

(3041096) Erythrocytes [Presence] in Urine by Automated

856

6763

1.36

12.51

5.0

3.5

—

(3020891) Body temperature

224

1344

1.71

12.44

8.3

4.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

212

2.82

12.16

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

751

5841

1.37

12.07

5.5

4.1

kg/l

1.0

1.89

115

891

(3000034) Microalbumin [Mass/volume] in Urine

294

2.52

12.04

3.7

3.4

mg/l

41.0

35.0

0.14

239

(3002256) Pathology report gross observation

496

3594

1.45

12.02

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

374

2.33

12.00

10.5

25.2

mmol/l

7.4

7.7

0.26

314

(3030981) Hyaline casts [#/volume] in Urine by Automated count

277

1776

1.61

11.90

4.5

2.9

e6/l

0.3

0.09

272

1745

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

108

519

2.12

11.83

1.6

1.5

—

(3003338) MCHC [Mass/volume]

2307

21008

1.32

11.75

44.2

21.7

g/l

329.6

333.0

49.67

2287

20813

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

429

2.23

11.72

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

110

535

2.09

11.68

1.8

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

128

661

1.97

11.54

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

2464

22676

1.33

11.46

36.3

17.9

38.5

39.5

5.86

1631

14484

(3016750) Collection duration of Urine

197

2.82

11.43

2.0

min

485.2

489.8

0.10

140

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

869

6963

1.34

11.39

1.7

1.6

mmol/l

1.7

1.3

19.54

746

5743

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

226

1412

1.64

10.78

6.2

5.2

1.7

1.6

0.36

214

1324

(42529406) Shigella sp [Presence] in Stool by Culture

127

670

1.93

10.78

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

126

667

1.92

10.59

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

377

2.23

10.50

1.2

1.1

u/ml

46.5

39.7

—

(3017704) Immunofixation for Urine

184

2.80

10.48

1.2

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

346

2.28

10.44

1.6

1.7

—

(3022689) Creatine [Moles/volume] in Urine

3.82

10.20

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

151

858

1.80

10.17

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

202

1249

1.66

10.05

1.4

1.3

u/ml

382.6

255.5

0.98

189

1143

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

426

2.12

9.91

1.7

1.5

—

(3044927) Protein electrophoresis panel - Urine

330

2.27

9.81

1.4

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

203

2.64

9.74

1.8

1.3

promille

1.4

1.1

0.63

157

(3051611) Lipemic interference index of Serum or Plasma

285

2.34

9.43

4.3

3.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

218

1397

1.60

9.41

6.4

5.2

0.8

0.9

1.23

206

1311

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

342

2416

1.46

9.39

7.2

4.1

mmol/l

1.2

0.67

317

2120

(40768804) Tissue Pathology biopsy report

1205

10297

1.27

9.30

2.3

2.2

—

(3026480) Teichoate Ab [Titer] in Serum

7.03

9.28

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

106

555

1.94

9.25

1.7

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

115

3.15

9.18

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

467

2.02

9.14

1.7

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.85

8.95

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

7.25

8.84

3.6

2.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.67

8.82

2.9

1.4

ng/l

243.5

157.3

0.79

(3011985) Renin [Units/volume] in Plasma

347

2.16

8.72

1.1

1.4

mu/l

96.6

81.2

0.18

306

(3000093) Morphology [Interpretation] in Blood Narrative

296

2.25

8.67

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

138

803

1.75

8.62

1.4

1.5

ug/g

249.4

257.5

0.20

490

(44790047)

324

2.19

8.53

1.5

1.4

—

(44790049)

324

2.19

8.53

1.5

1.4

—

(44790048)

324

2.19

8.53

1.5

1.4

—

(44806118)

324

2.19

8.53

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

419

2.03

8.44

1.6

1.4

—

(3042631) Mycobacterium sp identified in Specimen

469

1.97

8.35

2.6

2.7

—

(3022145) Colonoscopy Study observation

398

2952

1.40

8.34

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

161

2.69

8.31

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

561

4396

1.33

8.27

1.2

u/ml

3.1

2.0

0.42

134

1127

(3001729) Color of Synovial fluid

5.35

8.20

2.1

1.2

—

(3004775) Volume in Urine collected for unspecified duration

280

2.24

8.04

2.0

2.2

658.5

624.1

0.30

174

(3024980) IgG subclass 4 [Mass/volume] in Serum

368

2.06

7.90

1.4

1.6

g/l

0.8

0.9

0.33

284

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

174

1104

1.61

7.86

2.5

3.3

pmol/l

4.1

4.4

2.80

158

967

(3022806) Fractional oxyhemoglobin in Capillary blood

427

1.97

7.68

2.6

1.9

88.9

89.5

0.38

421

(40768441) Liver Pathology biopsy report

174

2.55

7.66

1.4

1.3

—

(3035880) pH of Pleural fluid

229

2.34

7.63

1.4

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

105

586

1.82

7.59

1.2

1.4

nmol/l

1.1

0.9

2.04

483

(3049717) Cytology report of Urine Cyto stain

231

1578

1.50

7.52

3.1

2.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

546

1.84

7.44

1.3

1.2

u/l

45.0

47.1

0.04

477

(3037556) Urate [Mass/volume] in Serum or Plasma

3.08

7.43

1.9

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

125

2.82

7.42

1.1

3.3

mg/l

58.2

63.9

0.21

(3019832) Treponema pallidum Ab [Presence] in Serum

132

794

1.69

7.37

1.7

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

120

2.85

7.37

1.0

1.1

u/l

104.9

95.5

0.23

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

120

2.85

7.37

1.0

1.1

u/l

34.9

35.6

0.03

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

149

2.64

7.29

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

149

2.64

7.29

1.2

1.5

—

(3019225) pH of Specimen

391

2956

1.37

7.27

8.0

4.4

—

(3002619) Bacteria identified in Specimen by Culture

4.15

7.27

1.7

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

105

2.97

7.22

2.9

1.7

umol/l

72.4

113.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

235

2.28

7.21

1.6

u/ml

33.4

27.1

—

(3045414) Leukocytes [Presence] in Urine

185

1216

1.55

7.21

2.8

1.9

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.27

7.10

3.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

256

2.21

7.10

1.8

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

256

2.21

7.10

1.7

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.23

6.96

1.2

—

(3051651) Icteric interference index of Serum or Plasma

159

2.53

6.92

5.0

3.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

266

2.16

6.88

2.1

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

266

2.16

6.88

2.1

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

266

2.16

6.88

2.1

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

172

2.46

6.84

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

341

2.01

6.80

4.3

4.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.43

6.76

3.5

3.4

—

(4034850)

141

883

1.62

6.76

19.9

11.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.30

6.41

1.1

miu/ml

1584.7

1562.8

0.03

(3039000) Anion gap in Blood

124

765

1.64

6.33

8.3

7.1

mmol/l

12.8

11.3

4.91

114

686

(3018572) Chloride [Moles/volume] in Blood

124

765

1.64

6.33

8.3

7.1

mmol/l

104.5

105.2

0.88

114

686

(21494434) Karyotype in Bone marrow

297

2.04

6.25

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

4.43

6.23

1.0

1.2

mmol/l

5.2

6.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

318

2.00

6.22

1.1

1.4

pmol/l

352.3

263.8

0.84

245

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1520

0.58

6.14

1.8

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

207

2.24

6.10

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

307

2.01

6.08

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

287

2.04

6.06

1.7

1.8

—

(3023419) Bacteria identified in Sputum by Culture

413

1.86

6.05

2.4

2.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

203

2.23

5.94

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

142

2.48

5.85

1.1

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

142

2.48

5.85

1.1

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

214

1517

1.44

5.82

2.6

2.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

180

2.29

5.78

1.9

2.0

ug/min

183.2

225.9

0.14

(3017354) Segmented neutrophils/100 leukocytes in Blood

334

1.93

5.78

3.3

3.9

62.9

57.2

0.87

207

(3027135) IgG subclass 1 [Mass/volume] in Serum

232

2.13

5.76

1.4

1.3

g/l

6.8

6.9

0.05

161

(3024139) IgG subclass 3 [Mass/volume] in Serum

232

2.13

5.76

1.4

1.3

g/l

0.5

0.4

0.31

161

(3028192) IgG subclass 2 [Mass/volume] in Serum

232

2.13

5.76

1.4

1.3

g/l

2.7

3.0

0.53

162

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

199

1395

1.45

5.74

1.2

1.3

au/ml

47.2

68.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.90

5.62

1.0

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

2.77

5.62

1.7

1.4

27.8

23.4

0.21

(4062490)

235

2.10

5.58

1.4

1.3

—

(3045424) Erythrocytes [Presence] in Urine

448

1.78

5.52

1.8

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

376

1.85

5.49

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

314

2401

1.34

5.43

2.1

2.3

ug/g

222.9

176.3

0.64

256

1891

(3022621) pH of Urine by Test strip

249

1837

1.38

5.41

4.0

3.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.29

5.30

1.3

1.2

—

(3014891) Appearance of Pleural fluid

3.29

5.30

2.2

1.5

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

11.28

5.29

5.4

6.6

umol/l

347.0

351.9

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

229

2.07

5.17

1.5

1.8

mg/l

5.7

4.6

0.61

219

(3004616) Nuclear Ab [Presence] in Serum

284

1.95

5.16

1.2

—

(3045142) Bone marrow Pathology biopsy report

363

1.83

5.12

1.2

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

102

635

1.63

5.10

1.5

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

217

2.09

5.09

1.2

1.1

—

(40768443) Skin Pathology biopsy report

172

1204

1.45

5.04

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

380

1.81

5.02

3.0

2.1

mg/l

29.1

24.4

0.26

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.80

5.01

1.1

—

(40761536) Microorganisms panel - Urine sediment

295

2264

1.33

4.99

6.3

4.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

2.82

4.97

1.3

umol/l

10.9

9.3

0.15

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.82

4.97

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

105

2.58

4.96

1.1

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

154

2.29

4.95

2.1

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

154

2.29

4.95

2.1

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

154

2.29

4.95

2.1

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

154

2.29

4.95

2.1

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

148

2.31

4.93

1.8

2.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

168

2.22

4.87

3.0

2.0

umol/l

11.0

19.1

—

(4146454)

355

1.82

4.85

2.7

2.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

942

0.53

4.84

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

11.45

4.78

10.1

11.1

—

(21494755) Public health laboratory ask at order entry panel

1314

0.61

4.77

1.4

—

(3033799) Differential panel - Peritoneal fluid

2.75

4.77

2.6

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

484

1.69

4.76

1.2

—

(36660697) Celiac disease serology panel - Serum

213

1570

1.38

4.68

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

374

1.78

4.68

5.9

4.5

umol/l

341.3

343.7

0.05

320

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

389

1.76

4.67

1.1

1.0

—

(3003694) ABO and Rh group [Type] in Blood

791

6860

1.20

4.66

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

179

2.14

4.59

3.9

3.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

783

0.50

4.59

1.4

1.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

166

2.18

4.58

1.4

54.9

66.2

0.64

137

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

134

912

1.49

4.56

1.4

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.69

4.41

3.1

2.1

e6/l

40250.3

23670.8

0.19

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

258

1.91

4.39

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

157

2.18

4.33

1.6

2.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

317

1.81

4.32

1.2

u/ml

2.2

4.8

2.41

146

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

211

2.00

4.31

1.7

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

325

1.80

4.30

1.2

u/ml

1.5

3.9

1.50

103

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

122

827

1.49

4.25

1.4

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

102

2.46

4.21

1.4

1.7

—

11.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

255

1.90

4.21

1.1

—

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

179

2.08

4.20

1.8

1.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

3.15

4.20

1.0

1.1

—

6.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

180

2.07

4.15

1.8

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

112

751

1.51

4.12

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

2.80

4.12

2.8

1.9

—

(3052592) Norovirus Ag [Presence] in Stool

2.94

4.00

1.4

—

(1761868) Lipid panel - Serum or Plasma

703

8038

0.84

3.99

3.5

3.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.94

3.97

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

225

1.92

3.96

1.1

96.3

95.9

0.05

209

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1812

16954

1.15

3.89

4.9

5.3

ug/l

2.9

3.7

1.08

1612

15138

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

338

1.73

3.80

1.2

1.3

nmol/l

0.6

0.70

322

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.43

3.80

3.2

2.4

e6/l

247.9

7740.8

0.53

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

160

2.07

3.76

2.3

1.5

u/field

3.8

2.2

0.44

119

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

340

1.72

3.73

1.2

1.3

nmol/l

0.2

0.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

297

1.76

3.67

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

306

1.74

3.61

1.2

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

392

3251

1.23

3.60

3.4

4.2

ug/l

11.3

22.5

1.04

326

2744

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.36

3.57

1.3

1.2

ratio

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

150

2.08

3.57

2.5

2.7

32.2

36.6

0.60

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.85

3.52

1.5

1.8

75.2

61.7

—

(3013727) Leukocytes other/100 leukocytes in Blood

105

2.30

3.52

5.1

3.8

63.1

53.6

1.60

100

(3024522) Salmonella sp identified in Specimen by Organism specific culture

362

1.67

3.50

1.7

1.4

—

(4268621)

214

1.88

3.49

1.8

2.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

100

682

1.48

3.45

2.7

3.4

u/ml

2469.3

985.2

0.26

630

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

372

1.65

3.42

1.6

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

458

1.58

3.41

1.1

—

(3003181) Sodium [Moles/volume] in Urine

538

1.54

3.40

1.4

1.3

mmol/l

52.8

64.1

1.98

427

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

365

1.66

3.40

1.7

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

153

2.04

3.40

2.4

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

246

1.80

3.36

1.5

2.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.62

3.30

1.6

3.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.62

3.30

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

361

1.65

3.28

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

361

1.65

3.28

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

362

1.64

3.25

1.6

1.4

—

(4198724)

2.79

3.25

1.1

1.7

—

(3011412) CD3 cells [#/volume] in Blood

227

1.82

3.24

2.7

2.2

e9/l

1.1

1.0

0.05

125

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.28

3.19

1.5

1.6

ug/l

10.3

0.01

(3047007) Chlamydophila sp Ab [Presence] in Serum

258

1.75

3.17

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

151

2.00

3.14

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

151

2.00

3.14

1.6

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

172

1.93

3.14

5.2

13.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

358

1.63

3.13

1.7

1.4

—

(4306422)

297

1.69

3.12

1.2

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.01

3.05

1.5

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

385

1.60

3.03

3.1

2.5

u/ml

15.2

186.2

0.91

378

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

401

1.58

3.02

1.0

1.1

iu/ml

1.2

42.8

3.34

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

154

1.96

2.99

3.0

2.1

e6/l

715.3

493.3

1.09

135

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

340

1.63

2.97

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

272

1.70

2.94

1.8

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

4.71

2.92

1.1

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

296

1.67

2.90

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

251

1.72

2.88

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

115

2.09

2.88

2.3

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

115

2.09

2.88

2.2

2.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.44

2.87

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

359

1.60

2.87

3.3

3.7

—

(3040893) Potassium [Moles/volume] in Capillary blood

6.68

2.86

1.3

1.9

mmol/l

4.2

4.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

136

1.99

2.85

1.3

1.4

1.9

2.1

0.08

117

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

157

1.92

2.84

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

157

1.92

2.84

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

157

1.92

2.84

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

116

2.08

2.82

2.5

2.1

—

(3000012) Reticulocyte production index

172

1.87

2.81

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

137

1.98

2.80

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

137

1.98

2.80

1.1

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

180

1.84

2.77

2.5

2.1

e6/l

663.7

590.3

0.18

(3016879) Cocaine [Presence] in Urine

300

1.64

2.77

1.5

2.2

—

(3028433) Virus identified in Specimen by Culture

2.27

2.77

1.2

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

8.34

2.75

7.2

3.3

e6/l

46.0

67.8

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1.88

2.70

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1.88

2.70

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1.88

2.70

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.51

2.70

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

146

1.93

2.70

1.1

—

(3011288) Drugs identified in Urine by Screen method

212

1.75

2.66

1.9

2.9

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.22

2.63

1.2

—

(3000492) Spirometry study

273

2259

1.23

2.61

1.7

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

647

1.42

2.61

3.7

2.3

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

120

2.01

2.60

1.3

1.4

26.0

21.9

0.22

110

(3019174) dRVVT (LA screen)

4.67

2.59

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

212

1709

1.26

2.58

3.3

3.4

e9/l

5.1

4.3

2.51

137

1248

(44806071)

4.01

2.56

1.1

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

194

1.76

2.50

1.2

1.1

—

63.1

—

(3013512) EKG study

962

8825

1.13

2.49

5.8

4.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.47

2.48

1.4

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

295

1.60

2.44

1.2

1.3

nmol/l

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.24

2.44

1.5

1.2

mmol/l

1.2

1.6

0.53

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.95

2.41

3.7

2.3

u/field

0.2

0.4

—

(3000764) Benzodiazepines [Presence] in Urine

321

1.57

2.38

1.5

2.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

6.26

2.37

1.2

1.3

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

6.26

2.37

1.8

1.0

u/field

2.8

0.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

104

2.03

2.36

3.8

2.5

—

(3014271) Vancomycin [Susceptibility]

183

1.76

2.35

2.8

2.9

—

(3020491) Glucose [Moles/volume] in Blood

207

1.70

2.30

2.3

1.8

mmol/l

7.4

6.9

0.61

135

(3027008) Opiates [Presence] in Urine

324

1.55

2.29

1.5

2.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

155

1.81

2.29

2.4

2.1

15.8

17.1

0.17

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.69

2.27

1.1

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.46

2.27

1.9

2.0

mmol/l

1.2

0.35

(3028300) Cannabinoids [Presence] in Urine

325

1.55

2.27

1.5

2.1

—

(3004451) EKG impression Narrative

171

1.76

2.24

1.4

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

179

1.74

2.22

3.1

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

135

1.86

2.22

1.2

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.56

2.21

2.6

4.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.24

2.17

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

4.29

2.15

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.01

2.10

7.5

7.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.71

2.10

2.2

2.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.21

2.09

1.5

1.4

—

(4035726)

282

2399

1.19

2.08

1.5

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.26

2.07

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.08

2.06

3.7

2.1

—

(4010399)

234

1958

1.21

2.06

1.5

1.4

—

(3027944) Amphetamines [Presence] in Urine

317

1.52

2.06

1.5

2.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

4.00

2.04

1.7

1.9

3.0

1.4

—

(3019977) pH of Arterial blood

215

1.63

2.03

2.4

2.5

7.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

118

1.87

2.01

1.5

1.3

ug/l

1.6

202.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

248

1.58

1.98

1.2

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

156

1.74

1.96

1.1

1.3

nmol/l

1.7

1.0

1.78

112

(3043410) Blood group antigens tested for on Red Blood Cells

2.03

1.95

1.9

2.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.55

1.94

10.8

7.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.75

1.93

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.12

1.92

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.57

1.92

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.25

1.90

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

251

1.56

1.89

1.2

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

2.31

1.87

1.8

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

159

1.70

1.85

4.3

3.4

—

(3000285) Sodium [Moles/volume] in Blood

2.40

1.85

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

167

1.68

1.83

1.8

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

214

1.59

1.82

1.4

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.13

1.81

2.0

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

504

1.38

1.79

1.2

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.44

1.75

1.2

—

(4015189)

1.90

1.75

1.7

2.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

541

1.36

1.74

1.4

u/l

8.9

7.5

0.44

437

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.67

1.72

5.3

4.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.85

1.71

1.2

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.16

1.66

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.80

1.65

1.0

1.4

—

(4281824)

168

1.61

1.55

1.6

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.89

1.54

1.4

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

122

1.73

1.54

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.28

1.53

1.1

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.34

1.52

1.2

1.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

101

802

1.27

1.51

1.0

1.1

—

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

123

1.71

1.50

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.86

1.50

1.3

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

250

1.49

1.50

1.3

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.95

1.48

1.1

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.44

1.47

2.1

2.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.37

1.45

2.0

2.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.50

1.45

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

2.12

1.44

1.7

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.42

1.39

2.4

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

150

1.60

1.37

2.2

1.5

g/l

1.0

0.9

0.33

150

(3044242) Glucose [Moles/volume] in Arterial blood

190

1.53

1.37

2.3

2.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.61

1.36

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.83

1.35

1.7

2.2

—

(4024509)

249

1.45

1.33

2.0

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.04

1.32

1.0

1.1

67.8

81.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.97

1.32

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

152

1.58

1.31

1.0

1.1

nmol/l

6.3

8.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

160

1.57

1.31

2.3

2.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.81

1.31

7.0

7.8

—

(3016330) Potassium [Moles/time] in 24 hour Urine

2.50

1.30

1.3

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

106

1.70

1.29

1.3

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.29

1.26

1.3

1.5

umol/l

47.4

45.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.05

1.26

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1079

0.80

1.26

1.2

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.23

1.24

1.3

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.63

1.21

1.2

1.5

umol/24h

293.2

343.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.72

1.21

1.6

2.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

547

0.73

1.20

1.4

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.31

1.18

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1416

13608

1.07

1.18

4.3

4.6

23.2

21.9

2.28

683

7094

(3011544) Albumin [Mass/volume] in Pleural fluid

2.05

1.15

1.1

1.2

g/l

13.6

18.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.85

1.13

1.3

1.4

ug/l

13.4

9.1

1.08

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.85

1.13

1.6

1.2

mmol/l

0.3

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.34

1.12

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

1.61

1.08

2.6

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

1.61

1.08

2.6

2.3

—

(1002224) Polysomnography panel

803

1.21

1.07

1.1

—

(3048879) Bone marrow aspiration report

1.64

1.03

1.8

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

491

1.27

1.03

1.1

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.77

1.00

1.1

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

317

1.33

0.99

1.3

1.2

miu/ml

171.4

180.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

638

1.23

0.99

1.6

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

495

1.26

0.97

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.96

0.0

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1013

9685

1.07

0.96

3.1

3.2

ug/l

0.8

0.32

743

6800

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

270

2442

1.11

0.95

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.95

0.0

10.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.69

0.95

2.7

2.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

1.51

0.94

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

235

1.37

0.91

1.4

1.2

—

(3006462) Nitrate [Presence] in Urine

126

1.51

0.91

3.6

3.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.63

0.90

3.1

2.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

110

1.55

0.90

1.2

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

272

2475

1.11

0.88

1.4

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.79

0.87

1.0

1.4

69.8

78.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.78

0.84

1.3

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.88

0.81

1.8

2.1

—

(4212803)

1.88

0.81

1.2

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.55

0.81

2.1

1.8

ug/l

54.0

53.9

0.00

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

285

1.30

0.80

1.2

mmol/l

9.2

7.5

2.27

206

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.82

0.79

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

1.67

0.78

1.4

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.78

0.0

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

191

1.36

0.77

2.0

1.5

—

71.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.77

0.76

1.0

1.5

—

(4133840)

1.64

0.75

1.4

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.08

0.74

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

208

0.67

0.74

3.1

3.7

u/ml

20.1

32.8

0.94

203

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.64

0.73

1.2

2.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

488

1.21

0.72

1.6

2.0

ug/l

17.7

25.1

1.31

481

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.00

0.72

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

185

1.35

0.71

1.2

mmol/l

12.6

12.1

0.22

(4211845)

134

1.42

0.71

3.6

3.3

—

(40765096) Chromosome analysis panel by Banding

101

1.49

0.70

1.3

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

265

1.29

0.69

2.4

1.9

u/field

2.2

1.9

0.10

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

224

1.30

0.64

1.1

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

563

1.18

0.61

1.2

mmol/l

4.2

3.9

1.24

520

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

318

1.23

0.58

1.3

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.72

0.57

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

124

1.37

0.55

1.2

1.3

u/l

16.2

22.4

0.36

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

238

0.75

0.53

1.0

ng/l

767.7

643.5

—

149

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

238

0.75

0.53

1.0

ng/l

43.0

43.9

—

149

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

237

0.76

0.51

1.0

ng/l

284.1

315.5

0.38

153

(3008295) Osmolality of Serum or Plasma

287

1.22

0.51

1.1

1.3

mosm/kgh2o

287.2

278.3

0.88

209

(40758292) HTLV I+II Ab panel - Serum

1.46

0.50

1.0

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.46

0.50

1.3

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

153

1.31

0.50

1.2

1.7

nmol/l

18.3

16.1

0.38

139

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

444

0.83

0.49

1.6

1.7

iu/l

3.4

4.2

0.23

136

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

1.32

0.47

1.0

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

1.47

0.47

2.9

3.4

ml/dl

13.5

15.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.46

0.46

1.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

876

0.89

0.46

5.3

4.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.60

0.45

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

119

0.67

0.45

1.1

1.3

—

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

156

1.28

0.45

1.0

1.4

u/ml

0.0

1.6

1.50

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

106

1167

0.91

0.44

1.5

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

648

1.13

0.44

1.2

1.3

mg/l

852.3

554.5

1.85

606

(3038177) Helicobacter pylori Ab [Presence] in Serum

302

1.19

0.44

1.2

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

554

1.14

0.44

1.2

1.4

e6/l

2826.0

783.3

0.44

462

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

555

1.14

0.43

1.2

1.3

e6/l

195.4

20.8

0.47

446

(3024869) Neuronal Ab [Presence] in Serum

1.38

0.41

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.41

0.0

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.41

0.0

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.41

0.0

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.6

—

70.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.41

0.0

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.41

0.0

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

128

1179

1.09

0.40

3.1

3.5

u/ml

984.8

4394.6

0.75

107

1023

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

103

0.68

0.39

1.1

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.34

0.39

1.3

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.39

0.38

1.4

1.3

—

(40768793) Breast Pathology biopsy report

269

0.82

0.38

1.1

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.34

0.38

2.0

1.5

umol/l

2.9

1.9

—

(3006270) Folate [Moles/volume] in Blood

252

1.19

0.37

1.3

1.2

nmol/l

359.4

318.9

0.50

199

(3051387) C reactive protein [Mass/volume] in Capillary blood

663

0.89

0.37

6.3

3.4

mg/l

35.3

30.8

0.45

414

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

112

1031

1.09

0.37

1.2

iu/ml

120.4

123.9

0.03

343

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

125

1.28

0.37

2.0

2.1

umol/l

70.9

57.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.29

0.36

1.1

1.6

pmol/l

16.3

15.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.66

0.35

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.65

0.35

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.40

0.35

1.2

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

188

0.80

0.33

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.68

0.33

1.3

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.28

0.32

1.0

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

607

1.11

0.32

1.3

1.2

—

(3016038) Potassium [Moles/volume] in Urine

202

1.19

0.31

1.2

1.1

mmol/l

34.2

35.8

0.12

172

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

212

1.18

0.30

1.4

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

361

3739

0.96

0.29

15.0

7.9

—

(3035285) Chloride [Moles/volume] in Venous blood

470

1.11

0.27

3.8

2.5

mmol/l

105.0

105.6

0.46

464

(3041354) Potassium [Moles/volume] in Venous blood

470

1.11

0.27

3.8

2.5

mmol/l

4.2

4.1

0.47

464

(4027681)

117

0.77

0.27

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

224

1.16

0.27

1.4

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

656

0.91

0.26

1.9

1.7

mg/l

6.2

3.2

0.88

465

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.69

0.26

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.22

0.25

1.2

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.28

0.24

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.19

0.21

7.2

3.2

umol/l

48.4

41.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

3.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

1.8

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

101

0.79

0.21

15.9

10.5

nmol/l

705.9

793.7

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.21

0.0

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

112

0.80

0.20

1.0

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

114

0.79

0.20

3.8

6.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.20

0.19

1.2

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

231

1.13

0.19

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.24

0.18

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

196

0.87

0.18

1.1

1.0

u/ml

0.8

0.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.19

0.18

1.6

1.3

—

(3020650) Glucose [Presence] in Urine

1.13

0.17

1.4

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.71

0.16

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.71

0.16

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.71

0.16

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.71

0.16

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.14

0.16

3.1

7.9

—

(3017569) Oxygen content in Arterial blood

187

1.12

0.15

3.1

2.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.76

0.15

1.2

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

119

0.84

0.15

1.0

1.1

ng/l

88.0

411.8

—

(3015183) Erythrocyte sedimentation rate

1.08

0.14

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

131

1.15

0.14

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

131

1.15

0.14

1.1

nmol/l

140.0

139.4

0.01

131

(3003888) Timothy IgE Ab [Units/volume] in Serum

201

0.89

0.13

1.1

1.0

u/ml

2.9

4.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

432

1.07

0.13

1.7

mu/l

236.5

279.2

1.09

408

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

209

0.91

0.11

1.1

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

188

0.90

0.11

2.2

2.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

167

0.90

0.10

1.1

1.0

—

(44806420)

115

1.13

0.10

1.7

2.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

294

2989

0.98

0.10

2.5

2.2

nmol/l

11.6

12.7

0.78

248

2593

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.11

0.09

1.0

1.1

—

0.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

232

1.08

0.09

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

232

1.08

0.09

1.3

1.4

—

(3000330) Specific gravity of Urine by Test strip

162

1584

1.02

0.09

5.1

3.6

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.09

0.08

1.0

umol/l

16.8

16.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

144

0.90

0.08

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

123

0.89

0.08

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

0.84

0.07

1.5

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.83

0.07

1.0

1.1

—

(3034426) Prothrombin time (PT)

1.07

0.07

1.1

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

461

1.04

0.07

4.0

2.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.07

0.07

1.3

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.87

0.06

1.3

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

102

0.88

0.06

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

899

1.02

0.06

1.1

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

151

1491

1.01

0.04

1.2

—

(44813793)

119

0.92

0.04

1.2

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

181

1.05

0.03

1.4

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

301

1.03

0.02

1.5

1.3

iu/l

23.5

0.00

253

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

354

3552

1.00

0.01

5.6

4.8

30.2

32.4

3.45

258

2323

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

704

1.01

0.00

2.1

1.9

pmol/l

198.2

208.2

0.28

654

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

939

1.00

0.00

2.0

1.8

nmol/l

35.3

43.0

3.11

896

(40768800) Prostate Pathology biopsy report

111

1114

1.00

0.00

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

231

1.00

0.00

1.2

1.1

u/ml

1.6

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

183

0.98

0.00

1.2

1.4

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.00

0.00

1.4

1.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.1

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.2

—

8.4

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.86

0.00

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.8

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(4038314)

0.00

0.0

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

1.5

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.4

—

0.2

—

(4094501)

790

1.00

0.00

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.0

1.6

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1492.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint GOUT_IDIO and mortality.

Females

Parameter	HR [95% CI]	p-value
GOUT_IDIO	2.162 [1.9, 2.46]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.25

During the follow-up period (1.1.1998 — 31.12.2019), 2832 out of 5476 females with GOUT_IDIO died.

Males

Parameter	HR [95% CI]	p-value
GOUT_IDIO	2.057 [1.84, 2.3]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.008

During the follow-up period (1.1.1998 — 31.12.2019), 5557 out of 14710 males with GOUT_IDIO died.

Mortality risk

Mortality risk for people of age

years, who have GOUT_IDIO.

N-year risk	Females	Males
1	0.256%	0.508%
5	1.421%	2.605%
10	3.318%	6.247%
15	5.785%	11.438%
20	10.119%	18.54%

Relationships between endpoints

↥

Index endpoint: GOUT_IDIO – Idiopathic gout

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Idiopathic gout

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints